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 LIGAND BINDING TO THE MUSCARINIC RECEPTOR 
EQUILIBRIUM AND KINETIC STUDIES 
CHAPTER I
 
INTRODUCTION
 
Historic review 
As is the case with many other hormone receptors, the first indication of muscarinic 
effects on the nervous system was obtained from the study of long-knoWn poisonous 
plants. Some plants that are now known to contain muscarinic ligands are the solanaccae 
Atropa bella donna (deadly nightshade), Datura stramonium (Jimson weed) and 
Hyoscyamus niger (henbane), the shrub Pilocarpus and the mushroom Amanita muscaria. 
Although Amanita muscaria was mainly used for its psychoactive qualities, the action of 
these plants on the heart was well-known. Von Bezold and Bloebaum found that 
atropine, the muscarinic agent present in the Solanaceae mentioned, blocks action of the 
vagus nerve (see Brown, 1989, for review). 
In 1869 Schmiedeberg and Koppe made extracts of Amanita muscaria and showed 
that they could use it to arrest a frog heart. They isolated the active alkaloid from their 
extracts and named it 'muscarine'. After administration of atropine, muscarine was 
without effect. Although at the time there was no notion of neurotransmitters, 
Schmiedeberg and Koppe (1869) suggested a connection between the actions of 
muscarine and electrical stimulation of the vagus nerve. 
In 1906 Hunt and Taveau synthesized acetylcholine and showed that it lowered 
blood pressurean effect that was blocked by atropine. In 1914 Dale found that at high 
concentrations acetylcholine increased blood pressure. This effect was similar to that of 2 
nicotine, which is why these two effects of acetylcholine and acetylcholine analogues 
were termed 'muscarinic actions' and 'nicotinic actions'. 
Dale and Dudley (1929) were the first to discover acetylcholine in an animal tissue 
in 1929 namely in bovine and equine spleen. The first evidence for chemical mediation 
of nerve signals came from an experiment done by Loewi in 1921. He showed that fluid 
that was collected from a frog heart after electrical stimulation of the vagus nerve could 
weaken the heartbeat of a second frog heart. In contrast fluid from an unstimulated heart 
was without effect. He named the active substance 'vagusstoff and five years later 
identified it as acetylcholine. This made acetylcholine the first recognized 
neurotransmitter. 
Smooth muscle tissue was used in the first successful receptor binding studies 
performed by Paton and Rang in 1965. Radiolabeled atropine was used in this study. 
With the availability of a number of radiolabeled muscarinic ligands, muscarinic 
receptors were soon demonstrated in the heart, central nervous system and secretory 
glands of many vertebrate species in addition to some neuronal cell lines (see Brown, 
1989, for review). These studies also showed that the receptor was located in the 
membrane fraction of these tissues/cells. 
In the 70s and 80s muscarinic receptors were solubilized from brain and heart tissue 
using a number of different detergents. Finally, in 1984 Peterson et al. were able to 
purify active receptor from porcine atria. At about the same time Haga and Haga (1985) 
obtained purified muscarinic receptor from porcine brain. 
Receptor subtypes 
Soon after purification of the muscarinic receptor was achieved, Kubo et al. 
(1986a,b) cloned the porcine cerebral muscarinic receptor and the cardiac muscarinic 
receptor (later termed the ml and m2 receptor) from cDNA libraries. The deduced 3 
sequence of the ml receptor was compared to the 132 adrenergic receptor (Bonner et al., 
1987), and a region of sequence homology was used to screen rat brain cDNA libraries. 
Using this technique the muscarinic receptor subtypes m3 and m4 were identified. At the 
same time another group succeeded at cloning all four muscarinic subtypes from genomic 
libraries (Peralta et al., 1987). A year later a fifth receptor subtype was identified 
(Bonner et al., 1988). The five subtypes are differentially distributed throughout the body 
with only m2 being present in atrial tissue. Working with atrial tissue therefore 
circumvents the problem of receptor subtype heterogeneity that has to be addressed with 
other tissues. Most muscarinic ligands show little subtype specificity. Although all 
muscarinic receptors share a fair amount of sequence homology, the ml, m3 and m5 
receptors couple preferentially to stimulation of hormone sensitive phospholipases, and 
the m2 and m4 receptors mainly inhibit adenylate cyclase. 
Receptor structure 
Hydropathy analysis of the amino acid sequence of muscarinic receptors suggests 
that they share a great deal of structural homology with rhodopsin as well as with other 
receptors such as the adrenergic receptors (Hu lme et al., 1990). All of these receptors 
contain seven transmembrane regions connected through alternating extracellular and 
intracellular loops as shown in Figure Ll. Along with structural homology, this  family of 
receptors shares the ability to interact with guanine nucleotide binding proteins. The N-
terminal end of the muscarinic receptor is located on the extracellular side of the plasma 
membrane and contains a number of potential glycosylation sites. The intracellular C-
terminus contains a palmitoylated cysteine residue, and the seven transmembrane regions 
are thought to form a helical wheel-type structure with the ligand binding site in the 
center (for review see Hulme et al., 1990). 4 
The transmembrane regions are relatively well conserved among G-protein coupled 
receptors and especially among muscarinic receptor subtypes. The second and third 
membrane-spanning domains contain 3 highly conserved aspartate residues. At least one 
of these aspartates is thought to participate in charge-charge interactions with the 
positively charged nitrogen moiety in most muscarinic agonists. Transmembrane regions 
4, 5, 6 and 7 each contain a proline residue that is conserved and that is likely to introduce 
a bend in the helix (Lefkowitz et al., 1988). Extracellular loops 1 and 2 each contain a 
cysteine residue, and the two residues have been shown to form a disulfide bond 
(Kurtenbach et al., 1989). Another residue that is conserved and that may play an 
important role in ligand binding and/or receptor function is a tyrosine residue in 
membrane-spanning domain 7. Site-directed mutagenesis studies are underway to 
examine the significance of this conservation. Another important feature of muscarinic 
receptors is the rather large intracellular loop that connects transmembrane regions 5 and 
6. At least part of the G-protein coupling specificity of different muscarinic receptor 
subtypes resides within this third intracellular loop. Subtypes 1, 3 and 5 on one hand and 
subtypes 2 and 4 on the other hand show the most homology in this region parallel with 
their preference for different effector systems. Experiments with chimeric receptors have 
shown that the membrane-proximal portions of the third intracellular loop are most 
important in determining effector specificity (Wess et al., 1990). 
G-proteins 
As mentioned above muscarinic receptors assert at least part of their effects through 
coupling to guanine nucleotide binding proteins. The first evidence for this interaction 
came from ligand binding studies in the presence of guanine nucleotides. GTP and its 
analogues decrease binding of muscarinic agonist, whereas antagonist binding is not 
affected (Berrie et al., 1979). Other evidence is the time course of effector activation, 5 
which is much slower for muscarinic receptors than, for example, for nicotinic receptors. 
Nicotinic receptors mediate the aforementioned nicotinic actions of acetylcholine and 
contain an ion channel. They assert their effects through directly controlling the flow of 
ions across the cell membrane, which is a very rapid effect. 
The mechanism of action of G-protein coupled receptors is complex and is 
illustrated in Figure 1.2. It is thought that upon binding of an agonist the liganded 
receptor binds to and activates a G-protein. Activation of the G-protein results in an 
exchange of GTP for GDP at the protein's nucleotide binding site. The nucleotide 
exchange is due to a higher dissociation rate of GDP in the presence of the receptor-
agonist complex (Tota et al., 1987). The GTP-bound G-protein then interacts with 
effector proteins such as adenylate cyclase, phospholipase C or ion channels. 
Guanine nucleotide binding proteins are heterotrimers comprised of a 39-45 kDa a-
subunit, a 35-36 kDa 13- subunit and a 5-10 kDa y-subunit (see Stryer & Bourne, 1986, for 
review) The  and y-subunits stay associated, whereas the a-subunit dissociates and 
reassociates during the activation cycle of the protein. The a-subunit carries the guanine 
nucleotide binding site. In the inactive state of the protein it is thought to have GDP 
bound and be associated with theft-subunit (Northup et al., 1983). 0.2 to 0.9 moles of 
GDP per mol 0-protein were found in highly purified preparations of 0-proteins 
(Ferguson et al., 1986). As mentioned above, binding of the receptor-agonist complex to 
the heterotrimeric G-protein results in a decrease in affinity for GDP, allowing GTP to 
bind in its place. GTP binding is thought to cause the G-protein to dissociate from the 
receptor as well as dissociate into its subunits. The GTP-bound a-subunit is then free to 
interact with effector proteins such as adenylate cyclase until the protein's endogenous 
GTPase activity hydrolyzes the bound GTP to GDP and inorganic phosphate. Upon GTP 
hydrolysis the a-subunit reassociates with the fry-subunit. Although it has been assumed 
that the fry-subunit only acts as a membrane anchor for the a-subunit and facilitates 
interactions with the receptor, it has also been suggested that the fry-subunit itself can 6 
interact with effectors (Logothetis et al., 1987; Jelsema & Axelrod, 1987). Complicating 
the picture is the fact that there are innumerable, different G-proteins that vary in their 
specificity both for the receptor and for different effectors. Cloning and sequencing have 
identified more than 30 different a-subunits, 4 different n- subunits and 5 different 
y-subunits (for review see Simon et al., 1991). Until recently it was thought that only the 
a-subunits confer specificity to G-proteins. Based on sequence similarities of the 
a-subunits, G-proteins were grouped into four classes: Gs, G Gq and G12. G the 
inhibitory G-protein, and G the stimulatory G-protein, are named for their effects on 
adenylate cyclase. Aside from sequencing, the four classes can be distinguished by use of 
certain bacterial toxins. Cholera toxin catalyzes the ADP-ribosylation of the Gs class, and 
Pertussis toxin, the agent that causes whooping cough, ADP-ribosylates the 0, class. In 
both cases NAD functions as the ADP-ribose donor. Evidence is now emerging that the 
13- and y-subunits are also important in determining the heterotrimer's specificity. Specific 
combinations of R- and y-subunits seem to be required for coupling to different receptors 
(Kleuss et al., 1991 and 1993). 
Second messenger systems 
Muscarinic ligands have been demonstrated to affect cellular levels of cAMP, 
phospholipid metabolites, calcium and cGMP as well as a number of ion conductances 
(for review see Brown, 1989). Levels of cAMP are regulated through an effect of the 
muscarinic receptor on the enzyme adenylate cyclase. Activation of the muscarinic 
receptor primarily leads to an inhibition of adenylate cyclase, although much higher 
concentrations of muscarinic agonists result in a stimulatory phase (W.K. Vogel, 
unpublished results). Whether the inhibitory and the stimulatory effect are mediated 
through the same adenylate cyclase subtype is unclear at the moment. The inhibition of 
adenylate cyclase is blocked by pertussis toxin, a toxin from Bordetella pertussis that 7 
catalyzes ADP-ribosylation of G, and Go (Gilman, 1987). This effect of pertussis toxin 
together with the requirement for GTP for inhibition of the enzyme (for review see Stryer 
& Bourne, 1986) suggests that G-proteins are involved in the coupling of muscarinic 
receptors to adenylate cyclase. 
Two mechanisms have been suggested for the interactions between muscarinic 
receptors, G-proteins and adenylate cyclase. Either the a-subunit of Gi directly interacts 
with and inhibits adenylate cyclase (Gilman, 1984a; Katada et al., 1984) or the 
muscarinic receptor causes the a-subunit of 0, to dissociate, resulting in an increase in 
cellular concentrations of the fry-subunit, which then combines with the a-subunit of the 
stimulatory G-protein, G$ (Birnbaumer, 1987). The latter mechanism suggest an indirect 
effect of Gi, inactivating the stimulatory G-protein and thus preventing stimulation of 
adenylate cyclase. 
Another mechanism by which muscarinic receptors can decrease cAMP levels is 
through activation of phosphodiesterases that catalyze the break-down of cAMP. This 
pathway has been demonstrated in thyroid slices (van Sande et al., 1977) and astrocytoma 
cells (Gross & Clark, 1977). The phosphodiesterase involved is stimulated by calcium­
calmodulin. As will be discussed later, muscarinic agonists increase cytoplasmic calcium 
levels, which could account for the observed phosphodiesterase activation. 
Similar to effects on adenylate cyclase, the regulation of phospholipid metabolism 
by muscarinic ligands has been well demonstrated. Muscarinic agonists activate 
phospholipases C, A2 and D. The most studied of these has been the activation of an 
inositol phospholipid-specific phospholipase C which in turn hydrolyzes phosphatidyl 
inositol -4,5- bisphosphate. The hydrolysis gives rise to the two second messengers 
diacyglycerol and inositol-1,4,5-trisphosphate. Inosito1-1,4,5-trisphosphate releases 
calcium from the endoplasmic reticulum and thus increases the cytoplasmic calcium 
concentration. Changes in cytoplasmic calcium concentration have profound effects on 
many proteins, including the mentioned calcium-calmodulin stimulated 8 
phosphodiesterase, protein kinase C and calcium-activated potassium channels. The 
other second messenger produced, diacyiglycerol, is together with calcium involved in 
activating protein kinase C. As with adenylate cyclase the effect of muscarinic ligands on 
phospholipase C involves guanine nucleotide binding proteins (Litosch et al., 1985). In 
Chinese hamster ovary cells (CHO cells) overexpressing the m2 receptor, this effect is 
sensitive to pertussis toxin (D.A. Bulseco, unpublished results). 
Muscarinic effects on cyclic GMP levels have been far less studied, but increases in 
cGMP concentration following muscarinic activation have been demonstrated in many 
tissues (Goldberg & Haddox, 1977). Since this phenomenon is only seen in whole cells 
or tissue, it is likely to be an indirect effect, although the second messengers involved 
have not been identified. 
Finally, the muscarinic receptor is involved in regulation of a number of ion 
channels. The system that is best understood is the inward rectifying potassium channel 
in the heart. This channel is opened during muscarinic activation leading to a 
hyperpolarization of the cell membrane up to several millivolts. This hyperpolarization is 
the basis for the actions of the vagus nerve on the heart. Patch-clamp studies have shown 
that no diffusible second messengers are involved in coupling of the receptor to the 
inward rectifying potassium channel. The involvement of a pertussis toxin sensitive G-
protein has been demonstrated (Breitweiser & Szabo, 1985). This G-protein was named 
Gk, but might be identical with G,3 (Gilman, 1987b). Whether the G-protein a- or 13y­
subunit is active in this pathway has been an issue of debate and has not been decided 
unequivocally. 
In the heart muscarinic ligands also affect calcium channels (Loffelholz & Pappano, 
1985; Trautwein et al., 1975). The observed decrease in calcium current is the result of 
the protein kinase C activation that follows muscarinic stimulation of phosphatidyl 
inositol hydrolysis (Nelson, M.T., personal conversation). 9 
Other ion conductances (e.g. sodium and chloride currents) have also been shown to 
be influenced by muscarinic stimulation. Much less is known about these responses, and 
they may be indirect effects caused by changes in the levels of second messengers already 
mentioned. 
Ligand binding 
Ligands can generally be divided into two classes: agonists and antagonists. 
Agonists cause the same response as the physiological ligand (i.e. acetylcholine in the 
case of the muscarinic receptor). Antagonists block the response of the physiological 
ligand. A large number of compounds are known to bind to the muscarinic receptor, most 
of which show no or little specificity for the different receptor subtypes. Although 
muscarinic ligands belong to very different chemical classes (e.g. cyclopentene and 
tetrahydrofurane derivatives), they share two important features: a fully or partially 
charged ammonium group and a nearby group of high electron density. The latter 
corresponds to the ester bond in acetylcholine. Muscarinic agonists are generally fairly 
small, hydrophilic molecules, whereas antagonists tend to be rather hydrophobic and 
often contain bulky aromatic groups (see Ringdahl, 1989, for review). The structures of 
some muscarinic ligands are shown in Figure 1.3. 
A number of radioactively labeled muscarinic ligands are commercially available 
and are used in binding studies on tissue slices, whole cells and membrane preparations. 
After binding of the labeled ligand comes to equilibrium, the bound and the unbound 
ligand have to be separated. In membrane preparations, separation can be achieved by 
filtration, centrifugation and dialysis. Filtration has the advantage that the bound label 
can be quantitated directly rather than be calculated from the difference between total and 
free ligand, which tends to reduce the error. On the other hand filtration can only be used 
accurately, if the dissociation rate is slow enough that the bound label is not lost during 10 
the washing steps. Independent of what separation method is used, the amount of 
nonspecific binding of the radioligand has to be determined. Nonspecific binding is 
defined as low-affinity binding to an infinite number of sites, whereas specific binding is 
saturable and of higher affinity. Nonspecific binding is determined as the amount of 
binding of the radioligand left after the specific binding sites are saturated with an 
unlabeled ligand (see Jary and Barfai, 1988, for review). 
Antagonists display hyperbolic binding isotherms as predicted for simple mass-
action binding to a single class of sites. Different antagonists displace each other 
completely over a concentration range of about two orders of magnitude. Binding of 
agonists displays more complex behavior. As is seen with other G-protein coupled 
receptors, muscarinic agonists can displace antagonists completely, but do so over a 
concentration range of 5-6 orders of magnitude. Agonists show shallow binding curves 
that sometimes contain marked inflections. Such a binding behavior can have a number 
of interpretations. The receptor may exist in different states or contain more than one 
binding site. In this case antagonist binds to all states/sites with the same affinity, 
whereas agonists have different affinities. Negative cooperativity only seen with agonists 
is another possible explanation for shallow binding curves, although it is inconsistent with 
the presence of inflections in some binding curves. Finally, shallow binding isotherms 
can be caused by other molecules that bind to the receptor and modulate its affinity for 
agonists. This is generally referred to as a ternary complex model. In the case where the 
modulating factor is present at concentrations lower than that of the receptor and binds to 
the receptor with high affinity, it becomes identical to a multiple state model. All of the 
models mentioned for agonist binding can be found in the literature (Burgen, 1987; 
De Lean et al., 1980). At present the model assuming multiple states of the receptor is 
most widely accepted. In most membrane preparations three states are required to 
adequately fit the binding data, whereas two states are sufficient in whole cells. Different 11 
binding models and their implications are discussed in more detail in the following 
chapter. 12 
Figure 1.1  Structure and amino acid sequence of the porcine m2 muscarinic receptor. Atrial mAcChR 
Extracellular Space 
o©0 
0 
Cytoplasm 
Figure 1.1 14 
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Figure 1.3  Chemical structures of muscarinic ligands. 17 
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CHAPTER II
 
EQUILIBRIUM BINDING STUDIES
 
INTRODUCTION 
It has long been known that neurotransmitter receptors that couple to guanine-
nucleotide binding proteins (G-proteins) bind ligands in a characteristic manner. At least 
in membranes and broken cell preparations antagonist binding displays a simple mass-
action relationship, as expected for non-cooperative binding to a homogeneous class of 
binding sites. Different antagonists recognize the same number of sites and are able to 
displace each other fully over a concentration range of two orders of magnitude. In 
contrast, a concentration range of up to 6 orders of magnitude is needed to fully displace 
an antagonist by an agonist. Due to this large concentration range agonist binding is 
generally studied in competition experiments using a radiolabeled antagonist as a tracer. 
The complex binding behavior of agonists was initially interpreted as binding to two 
noninterconvertible classes of independent sites with different affinities for agonists and 
the same affinity for antagonists. Guanine nucleotides leave antagonist binding 
unchanged, but affect the binding of agonists (Birdsall & Hulme, 1976). This effect has 
been interpreted as a shift of receptors from the high affinity to the low affinity state 
(Waelbroeck et al., 1982) without a change in the dissociation constant of either state. It 
was suggested that the high affinity state of the receptor is the result of the formation of a 
receptor G-protein complex (Kurose & Ui, 1983), whereas binding to the receptor itself is 
of low affinity. This fairly simple picture of receptor ligand interaction was invalidated 
when Birdsall et al. (1980) showed convincingly that for their preparations two classes of 
sites were insufficient in fitting the data, and at least three classes of sites were needed to 
obtain a satisfactory fit. The three classes were termed superhigh, high and low affinity 
classes of sites. Whereas two populations can be explained in terms of free receptors and 19 
receptor G-protein complexes, the physical identity of a third population is obscure. 
Receptor dimerization, complex formation with a second G-protein and posttranslational 
modifications are a few of the possibilities. It is also unclear what the significance of 
different affinity states is in terms of the receptor's ability to elicit cellular responses. 
Alternatively, the shallow nature of agonist binding curves has been attributed to the 
formation of ternary complexes involving the receptor, the agonist and a G-protein 
(De Lean et al., 1980). In this model an equilibrium exists between the receptor G-protein 
complex and its free components, and agonists support complex formation by binding 
with higher affinity to the complex than to the free receptor. A number of variations of 
the ternary complex model have been proposed, some of which include additional steps 
like a receptor isomerization (Samama et al., 1993) or G-protein subunit dissociation 
(Onaran et al., 1992). One of the weaknesses of any ternary complex model is that they 
fail to explain why purified receptors have been shown in some cases to have more than 
one affinity state (Peterson et al., 1984). 
Both models, the ternary complex model and the noninterconverting classes of sites 
model, persist in the muscarinic receptor literature and most data sets can be fit equally 
well to both models. However, the parameters obtained from either fit are completely 
different, and parameters from one fit generally carry no meaning in the other binding 
scheme. 
One would assume that the binding pattern of agonists is somehow linked to the 
mechanism by which G-protein coupled receptors elicit their cellular responses, and 
understanding this pattern seems crucial for the interpretation of any ligand induced 
phenomenon. Also, differences in binding patterns between whole cells and broken cell 
preparations have been observed, making the validity of in vitro binding assays 
questionable. For these reasons the following study was aimed at gaining a better 
understanding of agonist binding behavior. Four muscarinic agonists were chosen, 
including the physiological agonist acetylcholine and the partial agonist pilocarpine. 20 
Their binding to the pm2 mAcChR was studied in whole cells, broken cell preparations 
and membrane preparations. The effect of G-proteins and receptor density on muscarinic 
agonist binding was examined. Implications of the results for the choice of a binding 
model and for the differences between in vivo and in vitro studies are discussed. All of 
the in vivo binding experiments were carried out by Valerie A. Mosser. Experiments 
using purified muscarinic receptors were done by Dr. Gary L. Peterson. 21 
MATERIALS AND METHODS 
Abbreviations 
BCM, benzilylcholine mustard; CHO cells, Chinese hamster ovary cells; DTT, 
dithiothreitol; EDTA, ethylene diamine tetraacetic acid; EGTA, ethyleneglycol-bis-((3­
aminoethyl ether)-N,N,N',N'-tetraacetic acid; DHFR, dihydrofolate reductase; G-protein, 
guanine nucleotide binding protein; GDP, guanosine diphosphate; GppNHp, 
guanylylimido-diphosphate; GTP, guanosine triphosphate; GTP7S, guanosine 5'4)-(3­
thio-triphosphate); Hepes, 4-(2-hydroxyethyl-)-1-piperazine ethane sulfonate; NMS, N-
methyl scopolamine; Oxo M, oxotremorine M; PEI, polyethylene imine; pm2, porcine m2 
muscarinic receptor subtype; PMSF, phenylmethylsulfonyl fluoride; PTX, pertussis toxin; 
L-QNB, L-quinuclidinyl benzilate; Tris, Tris(hydroxy-methyl)amino methane; buffer A, 
10 mM Hepes, 5 mM MgC12, 1 mM EDTA, 1 mM EGTA, pH 7.4; buffer B, ice-cold 50 
mM sodium phosphate, 1 mM EDTA, pH 7.4; buffer C, 20 mM Tris HC1, 1 mM EDTA, 
0.1 mM PMSF, 1 mM DTT, 0.9% cholate, 73 mM sucrose, 5 mM MgC12, pH 8.0. 
Materials 
All radioligands were purchased from DuPont, New England Nuclear. Specific 
activities were 41.9 Ci/mmol for [3H] L-QNB, 80.4 Ci/mmol for [3H] NMS and 87.5 
Ci/mmol for [3H] oxotremorine M. Unlabeled oxotremorine M, pilocarpine and 
acetylcholine were purchased from Research Biochemicals Inc., 2.-hyoscyamine from 
Sigma and carbachol from Aldrich Chemical Company. All guanine nucleotides were 
purchased from Boehringer Mannheim. Pertussis toxin was obtained from List 
Biological Laboratories. Glass fiber filters were either from Schleicher & Schuell (#32) 
or from Whatman (GF/B). Benzilylcholine mustard was synthesized according to Gill 22 
and Rang (1966). The pko-neo vector was a generous gift from Dr. G.F. Merrill and was 
constructed by Dr. Doug Hanahan. 
Receptor preparation 
The receptor used in this study is exclusively the recombinant m2 subtype of the 
porcine muscarinic acetylcholine receptor. The gene for this receptor was cloned into the 
pSVE vector containing the gene for dihydrofolate reductase, which was then used to 
transform DHFR- Chinese hamster ovary (CHO) cells (Peralta et al., 1987a). 
Transformed cells were selected using the DHFR inhibitor methotrexate. The obtained 
stably transfected cell line overexpressed the m2 receptor at levels of 1-2 million 
receptors per cell and contained no endogenous muscarinic receptors. It expressed the 
stimulatory G-protein, G all three subtypes of the inhibitory G-protein, G and members 
of the 0, family but no Go (Dr. Janet Robishaw, unpublished results). The CHO cell line 
CHOipm2 was generated by transfection of CHO cells with 10 jig of a 20:1 (w/w) ratio of 
pSV2pm2 to pko.neo and selected at 100 gg/m1 G418. pSV2pm2, provided by M.I. 
Schimerlik, was obtained by cloning the pm2 receptor gene into the Hind III/BgLII site in 
place of the DHFR gene in pSV2DHFR (Subramani et al., 1981). 
When whole cells were used in binding assays, they were grown to near confluency 
on 2 mm culture dishes. They were then treated with agonists for 15 minutes before the 
radiolabeled tracer was added and allowed to equilibrate. After equilibration the media 
containing the free ligand was aspirated and the cells were washed, solubilized in triton 
and counted for bound radioligand. Nonspecific binding was assessed in the presence of 
an excess of an unlabeled antagonist. 
Alternatively, the cells were harvested, homogenized on ice with ten strokes in a 
Potter-Elvehjem homogenizer with a Teflon pestle and used in binding experiments or 
used to purify membranes. Membrane purification involved differential centrifugation 23 
and a sucrose gradient and was performed as described for porcine atrial membranes 
(Peterson & Schimerlik, 1984). 
Binding assays 
Agonist binding data for broken cell preparations and membranes were obtained 
using a competition assay. Membranes or broken cells were diluted to a L-QNB site 
concentration of 100-200 pM into buffer A and incubated with different concentrations of 
the unlabeled agonist typically ranging from 10 pM to 1 mM. In the case of the 
physiological agonist acetylcholine, 10µM eserine sulfate were added to inhibit any 
acetylcholine esterase present in the preparation. If binding was studied in the presence 
of guanine nucleotides, the nucleotides were added to the preparation before incubating 
with the agonist. After an incubation period of 20 minutes, the radioactive tracer, either 
[3H] L-QNB or [3H] NMS, was added and allowed to equilibrate for 2 hours. [3H] 
L--QNB was used at a concentration of 150 pM, [3H] NMS at 1.5 nM. Nonspecific 
binding was assessed in the presence of 10011M 2.-hyoscyamine, and the total binding site 
concentration was determined with saturating concentrations of the radiolabeled 
antagonist. After equilibration samples were filtered through #32 glass fiber filters either 
on a filter manifold or a Brandell cell harvester and washed with 4x3 mls of buffer B. In 
case of the positively charged tracer [3H] NMS the glass fiber filters were soaked in 0.1% 
PEI prior to use in order to reduce adsorption of the ligand to the filters. After filtration 
3.5 ml of a triton-toluene based scintillation cocktail was added and samples were 
counted for 5 minutes in a Beckman liquid scintillation spectrometer. 
PTX treatment 
Cells were treated with 100 ng/ml PTX for 14 hours prior to harvesting. 24 
Mustard treatment 
BCM at 100 µM was cyclized for 30 minutes at room temperature in 10 mM sodium 
phosphate, 1 mM EDTA, pH 7.4. Cells on tissue culture plates were rinsed and incubated 
with 1µM of the cyclized BCM at 37°C for 20-30 minutes. The cells were rinsed twice 
before use in ligand binding experiments. 
Reconstitution 
0.5 ml of the membrane preparation (-11.1.M receptor sites) were incubated with 
0.1 mM acetylcholine on ice for 30 minutes, after which 1 ml of purified G-proteins in 
buffer D were added. The final cholate concentration was 0.6%. The suspension was 
dialyzed overnight at 4°C against 0.5 L of buffer A, causing the fairly hydrophobic 
G-proteins to insert into the membranes. The dialysate was diluted 8-fold into buffer A 
and centrifuged at 40000 rpm for 1 hour. The resulting pellet was resuspended in 7 ml of 
buffer A, recentrifuged, resuspended in 0.5 ml of buffer A and frozen at -80°C. 
Data analysis 
All data were corrected for nonspecific binding by subtracting the amount of 
radioligand bound in the presence of 10011M L-hyoscyamine. Agonist binding data were 
generally analyzed in terms of a noninteracting three-site model. The equation describing 
this model is 
y  [L] (  F1  F2  F3
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where Y is the fractional saturation of the receptor with the radioactive tracer. [L] is the 
free tracer concentration and [I] the free agonist concentration assumed to equal the total 
agonist concentration. K is the dissociation constant of the tracer. F1, F2 and F3 are the 
fractions of total binding sites that show the dissociation constants K1, K2 and K3 for the 
agonist (so that F1 + F2 + F3 = 1). Agonist binding data were fit to this model using 
Marquardt's algorithm (Duggleby, 1984). The fractional saturation was normalized to 1 
in the absence of agonist. 
To evaluate the ternary complex model the equations describing the model were 
simulated using "Scopfit" (Simulation Resources Inc., Berrien Springs, MI). The 
concentrations of the receptor and the two competing ligands were determined 
experimentally, and the G-protein concentration, the dissociation constants and the 
coupling factors were fitted in "Scopfit" by an iterative method. 
Guanine nucleotide effects on Oxo M binding were fitted to a hyperbola described 
N] by the equation A = A. - [N] +K where A is the amount of [3H] Oxo M bound at the 
guanine nucleotide concentration N. A. is the amount of [3H] Oxo M bound in the 
absence of guanine nucleotides and K is the dissociation constant of the G-protein for the 
guanine nucleotide. B describes the maximum amount of Oxo M that dissociates as a 
result of nucleotide treatment. Again, Marquardt's algorithm was used to fit the data. 26 
RESULTS 
Figure 2.1 shows a typical binding curve for binding of the agonist carbachol to 
membranes of CHO cells overexpressing the m2 receptor. The binding curve was 
obtained by titrating the bound, radiolabeled antagonist [3H] NMS with unlabeled 
carbachol ranging in concentration from 10 pM to 1 mM. The graph shows the fractional 
saturation of the receptor with [3F1] NMS as a function of carbachol concentration. As 
mentioned in the introduction the binding curve is shallow and extends over a 
concentration range of 6 orders of magnitude. It was fit assuming three classes of agonist 
binding sites as described under 'Materials and Methods'. Two classes of sites were 
insufficient in fitting the data since fitting to two classes resulted in systematic errors, 
whereas fitting to three classes gave residuals randomly scattered around zero. In this 
experiment carbachol bound with the three dissociation constants K1 = (6.3 ± 6.8) nM, K2 
= (2.6 ± 1.5) JIM and K3 = (54 ± 31)1.IM to fractions of Fi = 0.20 ± 0.05, F2 = 0.52 ± 0.10 
and F3 = 0.28 ± 0.11 of L-QNB binding sites. The experiment shown is representative of 
at least ten experiments, and the shape of the binding curves and the fitted parameters 
were reproducible. The dissociation constants obtained varied somewhat from one 
experiment to the next, and up to 5-fold differences were observed. This variation may 
be due to differences in the membrane preparation used, but more likely stems from 
difficulties in fitting the data. 
To examine the effect of guanine nucleotide binding proteins on the agonist binding 
properties of the receptor, membranes containing the receptor were reconstituted with 
different amounts of G-proteins. Reconstitution was performed as described under 
'Materials and Methods' with the exception that 0.8 mL, 1 mL, 1.5 mL and 2 mL of G-
proteins in buffer C were used resulting in cholate concentrations of 0.55%, 0.6%, 0.68% 
and 0.89% before dialysis. Binding curves using the agonist carbachol were performed 
on the reconstituted membranes and are shown in Figure 2.2. The parameters obtained 27 
from the fitting routine are summarized in Table 2.1. Classes of sites that were present at 
15% or less of total ligand binding sites often gave dissociation constants that were not 
well determined due to problems in fitting the data. However, dissociation constants 
were reproducible in a large number of experiments. As can be seen in Figure 2.2, 
varying the G-protein to receptor ratio had a profound effect on the shape of agonist 
binding curves. This effect is reflected in an increase in F1, the fraction of superhigh 
affinity binding sites, in Table 2.1. Thus, the results from this experiment suggested that 
the ratio of G-proteins to receptor controlled the fraction of receptors showing superhigh 
affinity agonist binding without affecting any of the dissociation constants. It should be 
pointed out that it was possible to increase F1 to 72% whereas in the past a maximum of 
50% had been observed (Dr. M. Tota, unpublished results). 
Another way of looking at the role of G-proteins is to examine the effect of guanine 
nucleotides on agonist binding. Binding experiments using the agonist Oxo M were 
performed in the presence of different concentrations of the nonhydrolyzable GTP 
analogue GppNHp. Figure 2.3 shows the binding curves in the presence of zero and 84 
nM GppNHp. In the presence of GppNHp the binding curve was shifted to the right. 
This shift could be attributed to a decrease in the fraction of superhigh affinity binding, 
F1, as can be seen from the fitted parameters summarized in Table 2.2. No effect of 
GppNHp on the dissociation constants of the agonist was seen. Figure 2.4 shows a plot 
of the percentage of L-QNB sites showing superhigh affinity for Oxo M as a function of 
GppNHp concentration. Nonlinear least squares fitting of the data to an inverse 
hyperbolic function yielded an apparent dissociation constant for GppNHp of (1.64 ± 
0.48) nM. Even at very high concentrations of the guanine nucleotides (11 ± 2)% of 
L-QNB sites showed superhigh affinity for Oxo M. In this set of experiments the 
decrease in F1 seemed to be correlated with an increase in F3, the low affinity class of 
binding sites. The results shown suggested that superhigh affinity Oxo M binding can be 
used to quantitate the effects of guanine nucleotides on agonist binding and to obtain 28 
apparent dissociation constants for guanine nucleotide binding to G-proteins in the 
presence of liganded receptor. Reconstituted membranes were incubated with 1 nM [3H] 
Oxo M and varying concentrations of the four guanine nucleotides GDP, GTP, GTPrS 
and GppNHp for 1 hour.  1 nM [3H] Oxo M binding decreased as a function of nucleotide 
concentration for each of the guanine nucleotides tested and could be fit to a hyperbola. 
This procedure yielded the following apparent dissociation constants: KD(GDP) = (447 ± 
121) nM, KD(GTP) = (10.8 ± 1.7) nM, KD(GTP. S) = (0.55 ± 0.18) nM and KD(GppNHp) 
= (1.6 ± 0.9) nM. It can be seen from Table 2.1 that, if the G-protein to receptor ratio was 
low enough, the superhigh affinity binding site became unobservable. This was the case 
for some CHO cell clones that expressed the muscarinic receptor at very high levels. If 
homogenized cells from these clones were used in agonist binding experiments, no effect 
of guanine nucleotides was observed. Table 2.3 shows the results from binding 
experiment with three different agonists in the presence and absence of 10 AM of the 
nonhydrolyzable GTP analogue GTPrS. The nomenclature K2, K3, F2 and F3 was used for 
the sake of consistency with lower expression clones that in addition showed F1 and K1. 
The radioactive tracer used in these experiments was [3H] N-methyl scopolamine 
([3H] NMS). In the homogenized cell preparation used NMS bound to the same number 
of sites as L-QNB, and no differences were observed between agonist titration curves 
with [3H] NMS or [3H] L-QNB as tracer. In addition to the previously mentioned 
agonists carbachol and Oxo M the table shows binding parameters for pilocarpine. 
Pilocarpine is a partial agonist (Tota & Schimerlik, 1990), and at low receptor expression 
levels recognized only two classes of sites (data follows), whereas three classes of sites 
were needed to fit carbachol and Oxo M binding data obtained under the same conditions. 
Table 2.3 shows that the higher affinity site recognized by pilocarpine was sensitive to 
guanine nucleotides and disappeared in the presence of 10 AM GTP1S. The dissociation 
constant of the lower affinity site was unaffected in site of the observed variability of this 
parameter. 29 
As mentioned in the introduction, pertussis toxin catalyzes the ADP-ribosylation of 
the G, family of G-proteins. Table 2.4 shows carbachol and Oxo M binding data for a 
homogenized cell preparation that had previously been treated with pertussis toxin as 
described under 'Materials and Methods'. Like guanine nucleotides, pertussis toxin 
treatment only affected the superhigh affinity class of agonist binding sites. This class of 
sites was not observed after PTX-treatment, although the number of antagonist binding 
sites was unaffected. Unfortunately, the data did not allow a conclusion about the 
partitioning of the former F1 sites into the two lower affinity classes of sites. In whole 
cells only two affinities were observed with the agonists carbachol, Oxo M and 
acetylcholine and a single class of sites with the partial agonist pilocarpine (V.A. Mosser, 
unpublished results). None of these sites were affected by PTX treatment. 
In whole cells, binding curves were right-shifted by approximately an order of 
magnitude compared to homogenized cells and membrane preparations. This rightward 
shift was lost when the cells, while still attached to culture plates, were permeabilized 
with 0.05% digitonin (Mosser & Hirschberg, unpublished results). Permeabilization was 
monitored with trypan blue, which is excluded by intact cells but enters permeabilized 
cells, making them appear blue under a light microscope. Cells that die during 
permeabilization lift off from the culture plates and are lost during the wash steps. The 
following binding experiment was thus not complicated by the presence of dead cells. In 
contrast to permeabilization of whole cells, freezing and thawing of cell homogenates and 
use of culture media instead of buffer A was without effect on agonist binding curves. 
To try to discern between different ligand binding models it was of interest to 
systematically compare binding of different agonists. For this purpose four membrane 
preparations were chosen, and agonist titrations with carbachol, Oxo M, acetylcholine 
and pilocarpine were performed in parallel. The tracer used was [3H] NMS. The results 
are shown in Table 2.5 for the two preparations of lower receptor density and in Table 2.6 
for the higher receptor density preparations. The specific activities were 39 and 14 30 
pmoles receptor per mg protein for the low receptor density membranes and 377 and 150 
pmoles per mg protein for the membranes with higher receptor density. It should be 
pointed out that the fraction of pilocarpine binding sites listed as F2 is the site that is 
sensitive to guanine nucleotides and thus corresponds to F1 for the other agonists. Again, 
the guanine nucleotide sensitive classes of sites were either reduced in the case of 
pilocarpine or unobservable in membranes with high receptor density. In contrast, the 
agonist dissociation constants seemed unaffected by the 10-fold difference in specific 
activity between preparations 1 and 2 and preparations 3 and 4. For the ligands 
carbachol, Oxo M and acetylcholine the fraction of high affinity sites, F2, was close to 
50% in all of the membrane preparations. 
When whole cells were treated with BCM as described under 'Materials and 
Methods', about 70% of surface sites, defined as sites accessible to [3H1 NMS binding, 
were lost due to irreversible alkylation. The remaining sites showed a single apparent 
affinity for all four agonists previously mentioned when binding was measured in whole 
cells (V.A. Mosser, unpublished results). In contrast, when the treated cells were 
homogenized and the homogenate was used in binding experiments, three classes of sites 
were necessary to fit the data. The binding of Oxo M to homogenized BCM-treated cells 
is shown in Figure 2.5. It is virtually identical to binding curves obtained with untreated 
homogenized cells. Table 2.7 shows the fitted parameters for carbachol and Oxo M 
binding to homogenized BCM-treated cells. They are not significantly different from the 
previously reported parameters for untreated homogenized cells. This is in agreement 
with results from membrane preparations that had been treated with either BCM or 
acetylethylcholine mustard on the membrane-level instead of the whole cell-level (C. 
Hopf, unpublished results). 
The effect of low receptor numbers per cell can be more directly examined in cell 
lines that do not overexpress the receptor. The Chinese hamster ovary cell line CHOLEpn,2 
expresses the same subtype of the muscarinic receptor (porcine m2) as the previously 31 
discussed cell lines, but at approximately two orders of magnitude lower levels. Agonist 
binding to whole cells of this cell line could be fit assuming a single class of binding sites 
(V.A. Mosser, unpublished results). Alternatively, the cells were homogenized and 
binding of oxotremorine M was examined in the homogenate. The obtained binding data 
are shown in Figure 2.6 and required three classes of sites for adequate fitting. Nonlinear 
least squares fitting yielded the three dissociation constants K1 = (13 ± 3) nM, K2 = (0.40 
± 0.17) p.M and K3 = (25 ± 4) pM corresponding to fractions of sites F1 = 0.52 ± 0.05, F2 
= 0.28 ± 0.04 and F3 = 0.20 ± 0.06. While the dissociation constants did not seem to be 
affected by the low level of receptor, this binding curve showed the largest fraction of 
super high affinity agonist binding sites observed in nonreconstituted membranes. 32 
DISCUSSION 
The data presented generally fit well to a model assuming three noninteracting 
classes of sites producing no systematic errors. The following discussion will examine 
the results within the frame of this model and try to assign physical meaning to the 
classes of sites. Other binding models and their implication will also be discussed and 
compared to the three-site model. 
Results from reconstitution experiments, guanine nucleotide treatment and pertussis 
toxin treatment all pointed to a link between guanine nucleotide binding proteins and the 
superhigh affinity class of agonist binding sites. Increasing the G-protein to receptor ratio 
by reconstituting membranes with an excess of purified G-protein resulted in a large 
increase in the fraction of superhigh affinity binding sites. The total number of binding 
sites was unaffected, and the increase in F1 could be correlated with a decrease in F3. 
None of the dissociation constants were affected. The opposite effect was observed when 
the preparation was incubated with guanine nucleotides. With increasing guanine 
nucleotide concentration the fraction of superhigh affinity binding sites were shifted to 
low affinity. Again there was no effect on any of the dissociation constants. 
The results from both experiments agreed with results from rat heart membranes 
(Burgen, 1987) and were consistent with the F1 site being a receptor G-protein complex. 
This complex had to be able to form from the low affinity fraction of sites in the presence 
of unliganded G-proteins. Guanine nucleotides dissociated the complex causing the 
receptor to return to its low affinity state. To be consistent with the notion of 
independent, noninterconvertible classes of sites, the amount of receptor G-protein 
complex formed had to be limited by the availability of G-proteins, so that the receptors 
that are able to couple to G-proteins constitutes one class of binding sites and receptors 
without available G-proteins represent a second, independent class. The same conclusion 
is reached, if formation of the ternary complex involving the ligand, the receptor and a G­33 
protein is assumed to be a two-step process. Depending on the order of the ligand­
binding and the G-protein coupling step two such mechanisms are possible and both will 
be discussed briefly. 
(1)  R+L+G--'RL+G-,--='-RGL 
where R is the pm2 mAcChR, L the ligand and G the free G-protein.
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Only the second case predicts an effect of G-protein concentration on maximum 
formation of the ternary complex but not on the apparent dissociation constant for L. 
However, in order for this mechanism to be in agreement with the reconstitution 
experiment (Table 2.1, Figure 2.2), only 2% of detected GTPIS binding sites would be 
attributed to G-proteins capable of coupling to the pm2 receptor. This conflicts with 34 
results obtained with the same G-protein preparation that showed 30% of the GTErS sites 
being responsive to the muscarinic agonist carbachol (Tota, 1987). 
(2)  R + G + L = RG + L.-7=1 RGL 
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This mechanism predicts no effect of G-protein concentration on the apparent 
dissociation constant, if RT04>> GT04 or GT04 >> K,, R104. The latter case shows only one 
affinity since all of the receptor can be coupled to G-proteins. In order to see two 
affinities RTot has to be greater than GTot, which is equivalent to the previous statement 
that RG formation is limited by the availability of G-proteins. 
The two mechanisms shown can he added to form a square, which is referred to as 
the ternary complex model (Jacobs and Cuatrecacas, 1976) and will be discussed below. 
If one assumes that F, is the fraction of receptor responsible for the physiological 
response, the ligand could be activating this fraction by changing the affinity of the 
complex for GDP (Tota et al., 1987). A negative allosteric effect of agonists on GDP 
binding agrees with the finding that GDP caused dissociation of superhigh affinity [3H] 
Oxo M binding. However, GTP and its analogues have to cause Oxo M dissociation by a 
different mechanism, since no effect of agonists on GTPyS affinity was observed (Tota et 
al., 1987). Numerous such mechanisms are possible, but the most straight-forward seems 
to be a negative allosteric effect of GTP and its analogues on G-protein subunit 35 
interactions. That only a fraction of the total receptor population is active in causing a 
physiological response is not unreasonable considering that the receptor was expressed at 
unphysiologically high levels. However, in porcine atria the fraction that showed 
nucleotide-sensitive superhigh affinity agonist binding was still only 30% of total 
receptor (unpublished results). On the other hand, if one assumes that one or both of the 
lower affinity states are the active species, one has to again conclude that the ligand-effect 
lies downstream from G-protein coupling. Since G-proteins are involved in eliciting a 
physiological response, the active receptor species has to be capable of interacting with 
G-proteins. The lack of effect of guanine nucleotides and pertussis toxin on the two 
lower affinity states showed that G-proteins do not change the ligand affinity of these 
states. On the basis of microscopic reversibility it follows that ligand binding to these 
states does not alter G-protein coupling, thus the effect has to lie downstream. 
The IC50s for guanine nucleotide inhibition of 1 nM [3H] Oxo binding were in good 
agreement with thermodynamic dissociation constants obtained for GT13735S binding and 
GDP displacement of GT131,35S in the presence of muscarinic agonists (Tota et al., 1987). 
Why a fraction of superhigh affinity Oxo M binding sites seemed insensitive to GppNHp 
is unclear. 
Since the three-site model assumes that the fractions of sites with different binding 
affinity are ligand-independent, it predicts that they should be the same for different 
ligands. To test this hypothesis the experiment using four different agonists and four 
membrane preparations was initiated. In light of the difficulties in fitting the data, the 
fractions observed with the full agonists carbachol, Oxo M and acetylcholine were in 
agreement (Tables 2.5 and 2.6). In contrast the partial agonist pilocarpine clearly 
recognized different fractions. Fitting pilocarpine binding data from both whole cells and 
membrane preparations generally requires one class of sites less than fitting data from the 
other three agonists. The fraction that bound pilocarpine with higher affinity equaled the 
superhigh affinity fraction observed with the other agonists, if one assumes that fractions 36 
of 10% are not always observable when fitting to three classes of sites. Together with the 
guanine nucleotide sensitivity this data suggests that the site that was termed F2 for 
pilocarpine is the same as F1 for carbachol, Oxo M and acetylcholine. Further, 
pilocarpine binds with the same affinity to the other two classes of sites. Whether this 
difference is directly related to pilocarpine's action as a partial agonist is unclear at the 
moment. The factors relating the dissociation constants K1, K2 and K3 were similar for 
K K
carbachol, Oxo M and acetylcholine, and the following order was observed --3- >  > Ki  K1 
Ka  K3 
K2  for pilocarpine >  K2 .  It will be of interest to test whether any of these factors are an 
correlated to agonist efficacies in physiological assays. Whereas the fractions of sites 
were dependent on the receptor density of a given membrane preparation as previously 
discussed, no effect on any of the dissociation constants was observed. For all of the 
membrane preparations F2 seen with the full agonists tested was close to 50%. Whether 
this finding is significant is unclear. 
The same set of data was alternatively fit to a ternary complex model as described 
by Jacobs and Cuatrecacas (1976). The model is described by the following set of 
equations 
_. R+L  ,  RL  (K1) 
R+G  V'  RG  (K2) 
RL+G  ,
_1 RLG  (aK2) 
..I RG+L  V'  RLG  (aKI) 
where the thermodynamic dissociation constants are shown in brackets. In order to fit 
data to this model, the model was simulated allowing some of the binding parameters to 
vary, as described under 'Materials and Methods'. The fitted curve generally agreed well 
with the data and often looked identical to the curve obtained from fitting to the three-site 
model. For binding data obtained with the same ligand, the ligand-dependent parameters 37 
(K1 and a) were in good agreement, and preparation-dependent parameters (the G-protein 
concentration and K2) were similar for titration curves using the same preparation. 
However, several observations lead to the conclusion that the ternary complex model was 
inadequate in explaining the presented results. It was found that only a narrow range of 
receptor to G-protein ratios produced simulated binding curves shallow enough to fit the 
data. For example, if the previously discussed set of experiments was fit to the ternary 
complex model, the obtained receptor to G-protein ratio only varied by a factor of two 
between the preparations of low and high receptor density, although the receptor 
expression levels varied by a factor of 10. Also, if one assumes that the receptor G-
protein complex has higher affinity for agonists than the free receptor, the ternary 
complex model only allows for inflections in the top half of the binding curve, and only if 
the total G-protein concentration is less than the total receptor concentration. This clearly 
disagrees with the results in Figure 2.2, which show an inflection at 0.3 fractional 
saturation for a preparation with a 28-fold excess of GTP)S sites over QNB sites. 
The limitations of the ternary complex are discussed in detail by Wells and his 
colleagues (Lee et al., 1986 and Wong et al., 1986). The most obvious disagreement 
between the presented results and the ternary complex is the fact that in the absence of G-
protein coupling (e.g. after guanine nucleotide or pertussis toxin treatment) two classes of 
sites were required to fit the data. In the ternary complex model deviations from simple 
hyperbolic binding isotherms are entirely due to G-protein effects, thus without G-protein 
coupling one class of sites should be adequate to fit binding data. 
The idea that two classes of agonist sites are intrinsic to the receptor population is 
supported by data obtained with purified pm2 receptor (Peterson et al., 1984). The 
recombinant m2 receptor was purified from CHO cell membranes and stored in 0.08% 
digitonin and 0.016% sodium cholate. At low temperatures (equal to or less than 25°C) 
this preparation showed two classes of sites with respect to carbachol binding. The 
dissociation constants were similar to the two lower affinity dissociation constants in 38 
membrane preparations. For purified receptor preparations the shape of agonist binding 
curves is dependent on temperature and on detergent concentration (G.L. Peterson, 
unpublished results). Low temperature and low detergent concentration favored the 
appearance of the higher affinity class of sites, whereas only the low affinity class was 
seen at temperatures higher than 25°C. This finding suggested that receptor aggregation 
or isomerization is the basis for the two agonist affinities rather than differential post-
translational modifications. 
Results discussed in Chapter IV also pointed to the possibility of receptor 
aggregation. In order to produce two ligand affinities, aggregate formation and 
dissociation or receptor isomerization would have to be slow on the time scale of the 
ligand binding experiment. If these reactions occured rapidly, only one intermediate 
affinity would be measured. Since aggregate formation is most likely when the receptor 
concentration is high, the ligand binding experiments using homogenates from BCM-
treated cells and CHOLEm2 cells were initiated. Similar to untreated preparations, BCM-
treated cell homogenates showed approximately 50% of binding sites having intermediate 
affinity for carbachol and Oxo M. No significant effect on the relative amounts of F2 and 
F3 were observed. However, it should be kept in mind that the concentration of receptor 
protein was not reduced in BCM-treated cells. Only the number of free binding sites was 
reduced which may not effect receptor aggregation. In contrast, the receptor 
concentration was reduced by approximately 100-fold in CHOLEpm2 cells. Oxo M binding 
to CHOLEpm2 cell homogenates showed only 28% of binding sites having intermediate 
affinity. This finding agrees with the idea of receptor aggregation, although it certainly 
does not prove it. In Chapter IV it was concluded that reconstitution reduces receptor 
aggregation. Generally, reconstituted membrane preparations showed lower values for F2 
than nonreconstituted preparations. If the hypothesis of monomers and receptor 
aggregates being responsible for the two lower affinity states is extended to the whole cell 
studies described, it has to be concluded that homogenization affects the aggregation state 39 
of the receptor. This could happen either through a change in membrane organization 
(e.g. receptor patching) or a change in surface area going from whole cells to membrane 
vesicles/sheets. 
In conclusion, the presented data fit best to a model assuming three ligand­
independent classes of binding sites with the highest affinity class being a precoupled 
receptor G-protein complex. The physical identity of the two lower affinity classes 
cannot be assigned unequivocally, but the simultaneous existence of receptor monomers 
and dimers or higher aggregates agrees with the present observations. Although the 
presented discussion leaves many unanswered questions, it is hoped that it will be helpful 
in designing future experiments and instructive in evaluating different models. 40 
Figure 2.1  Carbachol binding to CHO cell membranes containing the recombinant pm2 
muscarinic receptor. 
Membranes from CHO cells overexpressing the receptor were diluted 500 
fold into buffer A resulting in a final L-QNB site concentration of 192 pM. 
Carbachol binding was determined as described under 'Materials and 
Methods' using 1.5 nM [3H] NMS as the tracer. The normalized fractional 
saturation of the receptor with [3H] NMS is plotted versus the competing 
concentration of carbachol. The line shows the best fit of the data to the 
equation describing the three-site model. Fitted parameterS were K = (0.56 
± 0.05) nM, K1 = (6.3 ± 6.8) nM, K2 = (2.6 ± 1.5)  K3 = (54 ± 31) pM, 
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Figure 2.2	  Effect of the G-protein to receptor ratio on carbachol binding. 
Reconstitution of CHO cell membranes with purified G-proteins was 
performed as described under 'Materials and Methods' using 0.8, 1, 1.5 and 2 
ml of G-proteins in buffer C. Panels A, B, C and D show carbachol 
displacement of 150 pM [3H] L-QNB for the four reconstituted preparations 
in order of increasing G-protein to receptor ratio. The receptor 
concentration in the assay was 212 pM, 153 pM, 71 pM and 47 pM, 
respectively. The fitted curves are shown as the solid lines and the 
parameters are listed in Table 2.1. 1.2 
1.0 
z
50 
9 
1.0 
o  0 
0.8 ­
0 5 ­
c 0.6­ c 0 
.2 
2, 
N 
0.4­
To
C 
O 
0 2 ­
To 
C 
0.2 
U. 
01 
0.00001  0.0001  0.001  0.01  0.1  to  too  1000 
0.0 
0.00001  0.0001  0.001  0.01  0.1  1  to  100  1000 
[Carbachol) (NM)  (Carbachol) (NM) 
1.0  C 
co  z 
9 
5"-' 
0.8 ­
.44
2 0A ­
*. 
U. 
0.00001  0.0001  0.001  0.01  0.1  1  10  100  1000 
(Carbachol) (pM)  (Carbachol) (NM) 
Figure 2.2 44 
Figure 2.3	  Effect of guanine nucleotides on Oxo M binding. 
CHO cell membranes reconstituted with purified G-proteins were diluted 
into buffer A to give a final receptor concentration of 130 pM. Oxo M 
binding was analyzed in competition with 150 pM [3H] L-QNB as described 
under 'Materials and Methods'. Binding curves in the absence of guanine 
nucleotides and in the presence of 84 nM GppNHp are shown. The fitted 
parameters are listed in Table 2.2. 1.2 
m z  a 
-IJ 
CI)  I-I 
1.0 
n 
.1..? 
p
I %. 
.c 
.§ 
c
0 
0.6 
CTi 
.2 
N 
w 
0.4 
To 
0 c 0.2 
0 
N 
U_ 
0.0 
0.00001 
1  1111111  1 
0.0001 
I  1111111 
0.001 
I  1  1111111 
0.01 
1  1  111111 
0.1 
1  1  1111111 
1 
1  1111111 
10 
1  I  I 111111 
100 
[Oxotremorine M] (MM) 
Figure 2.3 46 
Figure 2.4	  Superhigh affinity agonist binding as a function of guanine nucleotide 
concentration. 
F1 from Table 2.2 was converted into percent and plotted versus GppNHp 
concentration. The line represents a nonlinear least squares fit of the data to 
a hyperbolic function. The fitted parameters are listed in the text. 50 
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Figure 2.5	  Oxo M binding to homogenized, BCM-treated cells. 
CHO cells overexpressing the muscarinic receptor were treated with BCM 
as described under 'Materials and Methods'.  Following mustard treatment 
the cells were homogenized and diluted to a receptor concentration of 
230 pM in L-QNB sites. Oxo M binding was analyzed in competition with 
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Figure 2.6	  Oxo M binding to homogenized CHOLEma cells. 
CHOLEprn2 cells expressing the m2 muscarinic receptor at roughly 10000 
receptors per cell were homogenized and diluted into buffer A to a final 
receptor concentration of 59 pM. Oxo M binding was examined in 
competition with 1.5 nM [3F1] NMS. The line represents a fit of the data to 
the equation describing the three-site model. The obtained parameters were 
K = (1.22 ± 0.02) nM, K1= (13 ± 3) nM, K2 = (0.40 ± 0.17) gM, 1C3 = (25 ± 
4) RM, F1 = 0.52 ± 0.05, F2 = 0.28 ± 0.04 and F3 = 0.20 ± 0.06. 1.2  1111111  1  I  IIII111 
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Table 2.1	  Effect of G-protein to receptor ratio on carbachol binding. 
Listed are the parameters obtained from fitting the carbachol binding curves 
shown in Figure 2.2 to the equation describing the three-site model. [QNB sites]  [GTPyS sites]  GTPyS sites  F1  F2  K1  K2  K3 
L-QNB sites 
(nM)  (nM)  (nM)  (PM)  (PM) 
0.12  1.34  11  0.15±0.03  0.23±0.20  66±6 
0.11  1.51  14  0.10±0.05  0.29±0.07  2.34±3.29  0.91±0.74  35±7 
0.07  1.46  20  0.58±0.02  0.13±0.03  2.36±0.50  1.00±0.84  39±7 
0.08  2.33  28  0.72±0.04  0.08±0.09  1.84±0.72  0.81±2.60  14±9 
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Table 2.2	  Effect of guanine nucleotides on Oxo M binding. 
Binding of Oxo M was analyzed in the presence of different concentrations 
of GppNHp. The L-QNB site concentration in the assay was 130-140 pM 
and 150 pM [3H] L-QNB was used as tracer. The table lists the binding 
parameters obtained from nonlinear least squares fitting. [GppNHp]  K1  K2  K3  Fl  F2  F3 
(nM)  (nM)  (PM)  (MM) 
0.52±0.07  0.069±0.025  3.80±0.60  0.43±0.02  0.23±0.02  0.34±0.03 
0.42  0.80±0.14  0.184±0.047  6.30±2.14  0.35±0.02  0.43±0.03  .0.22±0.04 
0.84  1.78±0.38  0.197±0.049  7.94±2.59  0.32±0.02  0.46±0.03  0.22±0.04 
1.68  0.77±0.15  0.155±0.029  7.96±1.84  0.28±0.01  0.46±0.02  0.26±0.02 
2.52  0.55±0.10  0.204±0.052  6.04±1.82  0.30±0.01  0.42±0.04  0.28±0.04 
4.20  0.44±0.12  0.077±0.013  5.15±0.68  0.20±0.01  0.44±0.02  0.36±0.02 
5.88  3.55 ±1.65  0.216±0.064  6.20±1.43  0.16±0.03  0.48±0.04  0.36±0.05 
8.40  0.93±0.43  0.086±0.019  4.42±0.64  0.14±0.02  0.45±0.02  0.41±0.03 
84  1.72±1.21  0.140±0.073  5.21±0.97  0.14±0.03  0.33±0.04  0.53±0.05 
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Table 2.3	  Effect of guanine nucleotides on agonist binding to the lower affinity sites. 
Membrane preparation with a very high specific activity of 377 pmoles 
receptor per mg protein were diluted into buffer A to a final receptor 
concentration of 190-300 pM. Agonist binding was analyzed in competition 
with 1.5 nM [3H] NMS in the presence and absence of 10 RM GTP.VS as 
described under 'Materials and Methods'. The table shows the binding 
parameters obtained from fitting the data to the three-site model. Agonist  Guanine  K2  K3  F2  F3 
nucleotide 
(mM)  (i1M) 
Carbachol  1.82±1.08  15±10  0.63±0.24  0.37±0.24 
101IM GTPyS  0.33±0.44  2.67±3.31  0.57±0.29  0.43±0.29 
Oxo M  0.25±0.19  2.88±1.30  0.60±0.15  0.40±0.15 
101AM GTPyS  0.093±0.044  0.99±0.57  0.73±0.11  0.27±0.11 
Pilocarpine  0.14±0.15  26±4  0.19±0.05  0.81±0.05 
101..tM GTPyS  13±1  1.00 
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Table 2.4	  Effect of pertussis toxin treatment on agonist binding. 
Whole cells were treated with pertussis toxin for 14 hours, homogenized and 
diluted to 110 pM L-QNB sites into buffer A. Agonist binding was analyzed 
in competition with 1.5 nM [3H] NMS as described under 'Materials and 
Methods'. Parameters describing the binding of carbachol and Oxo M are 
shown. Agonist  PTX- Ki  K2  K3  Fi  F2  F3 
treatment 
(nM)  (MM)  (µM) 
Carbachol  1.52±1.30  0.75±8.17  5.3±4.3  0.31±0.06  0.07±0.55  0.62±0.55 
0.22±0.12  17.7±5.0  0.41±0.05  0.59±0.05 
Oxo M  2.76±1.56  0.39±0.10  10.7±2.9  0.20±0.03  0.57±0.03  0.23±0.04 
0.28±0.07  9.8±3.3  0.77±0.04  0.23±0.04 
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Table 2.5	  Binding of four muscarinic agonists to membrane preparations of low 
receptor density. 
The tables summarize the binding parameters obtained for binding of 
carbachol, Oxo M, acetylcholine and pilocarpine to two membrane 
preparations with specific activities of 39 and 14 pmoles receptor per mg 
protein,"respectively. The preparations were diluted into buffer A to a final 
receptor concentration of 100-240 pM and 1.5 nM [3H] NMS was used as 
tracer. Membrane  Agonist  Ki  K2  K3  Fl  F2  F3 
preparation 
(nM)  (PM)  (UM) 
1  Carbachol  6.3±6.8  2.6±1.5  54±31  0.20±0.05  0.52±0.10  0.28±0.11 
Oxo M  4.8±5.8  0.77±0.27  17±12  0.17±0.05  '0.70±0.06  0.13±0.08 
Pilocarpine  0.23±0.31  11±7  0.29±0.11  0.71±0.11 
2  Carbachol  29±16  6.1±3.2  177±254  0.38±0.05  0.52±0.08  0.10±0.09 
Oxo M  1.9±1.6  0.48±0.23  9.5±6.4  0.26±0.05  0.57±0.08  0.17±0.09 
Acetylcholine  0.65±0.21  0.32±0.08  6.4±2.6  0.36±0.02  0.52±0.03  0.12±0.04 
Pilocarpine  0.36±0.23  31±6  0.30±0.05  0.70±0.05 
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Table 2.6  Binding of four muscarinic agonists to membranepreparations of high 
receptor density. 
Binding parameters for binding of carbachol, Oxo M, acetylcholine and 
pilocarpine to membranes with specific activities of 377 and 150 pmoles 
receptor per mg protein are summarized.  Binding parameters were obtained 
from displacement studies using 100-240 pM L-QNB binding sites and 
1.5 nM [3H] NMS as a tracer. Membrane  Agonist  K2  K3  F2  F3 
preparation 
(1AM)  (MM) 
3  Carbachol  0.81±0.38  17±7  0.57±0.10  0.43±0.10 
Oxo M  0.25±0.13  2.9±1.3  0.60±0.15  0.40±0.15 
Acetylcholine  0.10±0.05  2.1±0.6  0.48±0.08  0.52±0.08 
Pilocarpine  0.16±0.19  15±3  0.11±0.04  0.89±0.04 
4  Carbachol  1.40±0.91  38±14  0.45±0.11  0.55±0.11 
Oxo M  0.54±0.30  5.6±5.1  0.76±0.18  0.24±0.18 
Acetylcholine  0.64±0.22  11±5  0.72±0.10  0.28±0.10 
Pilocarpine  0.30±0.54  19±4  0.10±0.06  0.90±0.06 
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Table 2.7	  Agonist binding to homogenized, BCM-treated cells. 
Fitted parameters are shown for the binding of carbachol and oxotremorine 
M to homogenized cells treated with BCM prior to homogenization. The 
data for oxotremorine M binding are shown in Figure 2.5. Receptor 
concentrations in the assay were 200 pM for carbachol binding and 230 pM 
for Oxo M binding. Agonist  Ki  K2  K3  F2  F3 
(nM)  (JAM)  (pM) 
Carbachol  42±14  9.68±4.62  132±57  0.27±0.02  0.42±0.09  0.31±0.09 
Oxo M  27±6  3.55±0.74  61±17  0.36±0.02  0.48±0.03  0.16±0.04 
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CHAPTER III
 
INFLUENCE OF pH ON BINDING OF MUSCARINIC LIGANDS
 
INTRODUCTION 
Several lines of evidence point to an ionic interaction of muscarinic ligands with a 
negatively charged residue on the receptor. Most, if not all, muscarinic ligands are either 
quaternary ammonium or sulfonium ions or tertiary amines expected to be protonated at 
physiological pH (Ringdahl, 1989). The positive charge resides at roughly the same 
distance from the end of the molecule on what has been termed the headgroup of the 
ligand. In the case of tertiary amine ligands it has been shown that protonation is needed 
for agonist activity (Burgen, 1965; Hanin et al., 1966). Asselin et al. (1983) showed that 
protonation was required for binding of the agonists pilocarpine and oxotremorine. The 
two ligands showed pKs of 7.05 and 8.60, respectively. In contrast binding of the 
antagonist scopolamine was also reduced at high pH, but the uncharged, deprotonated 
ligand retained significant affinity for the receptor. Scopolamine possessed a pK of 7.6 
and bound with a 6-fold higher dissociation constant in the deprotonated form (Asselin 
et al., 1983). This observed difference between muscarinic agonists and antagonists 
agreed with results from other studies suggesting that antagonist binding largely involves 
hydrophobic interactions whereas agonist binding is mainly facilitated by ionic 
interactions. Waelbrook et al. (1985) reached this conclusion through studies of the 
enthalpy and entropy changes involved in ligand binding to muscarinic receptors in rat 
heart membranes. Almost a decade earlier Aronstam et al. (1977) had suggested that 
binding of the antagonist L-quinuclidinyl benzilate to membranes from rat brain was 
mostly driven by hydrophobic interactions. 
Ionic interactions with the positive charge on muscarinic ligands requires a 
complementary negatively charged residue on the muscarinic receptor. Protonation of 67 
this residue should reduce, if not abolish, ligand binding. Thus it should be possible to 
determine the pKA of this acidic amino acid by measuring ligand binding as a function of 
pH. Indeed, Ehlert et al. (1980) showed that binding of the muscarinic agonist (cis)­
dioxolane was inhibited significantly below pH 5.5 The same author later determined the 
pKA governing N-methylscopolamine binding in rat heart and corpus striatum to be 5.5 
(Ehlert & De len, 1990). Another group studied the pH dependence of binding of a 
number of muscarinic antagonists in rat heart and found three titratable groups on the 
receptor (Birdsall et al., 1989). Binding of antagonists specific for the m2 receptor was 
governed by pKAs in the range of 6.5-6.8. In contrast antagonists without subtype 
specificity gave pKA values ranging from 5.5 to 6.1. The value of 5.9 for N­
methylscopolamine agreed reasonably well with the pKA determined by Ehlert et al. 
Finally, three pKA values were obtained in binding studies with the m2-specific 
antagonist methoctramine. Methoctramine belongs to a group of polymethylene 
tetramines (Cassinelli et al., 1986). This group is structurally quite different from 
classical muscarinic antagonists, but binds with high affinity to the m2 subtype. In 
addition to two pKAs with values of 5.4 and 6.8 methoctramine binding decreased as the 
pH increased above 7.0. It was concluded that an ionizable group with a pKA of 7.5 is 
involved in a conformational change. 
The identity of the residues with the mentioned pKAs has not been determined. 
Candidates for these residues should be conserved throughout the five muscarinic 
receptor subtypes and possibly in other monoamine receptors such as the adrenergic 
receptors. This requirement points to four conserved aspartic acid residues in 
transmembrane regions 2 and 3, namely asp 69, asp 97, asp 103 and asp 120 in the m2 
sequence. Mutagenesis studies and affinity labelling with the irreversible antagonist 
propylbenzylcholine mustard should yield more information about the involvement of 
these residues. In studies with purified brain muscarinic receptors the chemically reactive 
aziridinium compound [3H] propylbenzylcholine mustard mainly alkylated asp 103 (m2 68 
sequence), although asp 97 was labeled to a lesser degree (Curtis et al., 1989).  That the 
ligand binding site resides within the transmembrane regions agrees with proteolysis 
studies (Peterson, unpublished results) and comparisons with the structurally homologous 
rhodopsins. Also, studies with the p-adrenergic receptor using the fluorescent antagonist 
carazolol indicated that the ligand binding site is buried in the hydrophobic pore formed 
by the membrane-spanning domains (Tota and Strader, 1990). 
Valuable information has been revealed by site-directed mutagenesis. Mutation of 
the aspartate corresponding to asp 103 to asparagine in the ml muscarinic receptor and 
the p-adrenergic receptor greatly decreased ligand affinity (Fraser et al., 1989; Strader et 
al., 1988). Mutation of the aspartate corresponding to asp 69 to asparagine in the a2­
adrenergic receptor resulted in guanine nucleotide-insensitive agonist binding and a loss 
of physiological response (Wang et al., 1991). Site-directed mutagenesis studies in this 
laboratory using the porcine m2 muscarinic receptor agree with this finding. The 
mutation D69N resulted in loss of superhigh affinity, guanine nucleotide-sensitive agonist 
binding (W.K. Vogel and Dr. G.L. Peterson, unpublished results) as well as a loss of any 
detectable physiological response (W.K. Vogel, unpublished results). In a2-adrenergic 
receptors the aspartate corresponding to asp 120 seemed to be involved in receptor G-
protein coupling. Mutation of this residue to asparagine required 100-fold higher agonist 
concentrations to elicit the full physiological response and showed no superhigh, guanine 
nucleotide-sensitive agonist binding (Wang et al., 1991). The corresponding mutation in 
the pm2 muscarinic receptor was either not expressed or resulted in complete loss of 
ligand binding (Dr. D.J. Broderick, unpublished results). Finally, the mutation D97N did 
not adversely affect agonist or antagonist binding (W.K. Vogel and Dr. G.L. Peterson, 
unpublished results). Other conserved amino acid residues are pointed out in the 
Introduction. However, these residues do not contain groups ionizable in the right pH 
range to account for the observed pKAs. 69 
The following study was designed to answer the question whether agonist and 
antagonists interact with the same residue(s) on the muscarinic receptor, and to try to 
identify the residue(s) giving rise to the observed pKA(s). To address the first question 
the effect of pH on the binding of two agonists and two antagonists to wild-type pm2 
receptors was examined. Following, the involvement of specific amino acid residues in 
ligand binding was tested by studying the pH dependence of ligand binding to a number 
of site-directed mutants to the muscarinic receptor. 70 
MATERIALS AND METHODS 
Abbreviations 
CHO cells, Chinese hamster ovary cells; EDTA, ethylene diamine tetraacetic acid; 
EGTA, ethylene glycol-bis-(0-amino ethyl ether)-N,N,N',N'-tetraacetic acid; G-protein, 
guanine nucleotide binding protein; Hepes, 4-(2-hydroxy-ethyl)-1-piperazine ethane 
sulfonate; NMS, N-methylscopolamine; Oxo M, oxotremorine M; pm2, porcine m2 
muscarinic receptor; L-QNB, L-quinuclidinyl benzilate; Tris, Tris (hydroxymethyl amino 
methane); buffer A, 10 mM Hepes, 5 mM MgC12, 1 mM EDTA, 1 mM EGTA, pH 7.4; 
buffer B, 10 mM sodium acetate, 10 mM 3-(N-Morpholino) propane sulfonate, 10 mM 
Hepes, 5 mM MgC12, 1 mM EDTA, 1 mM EGTA; buffer D, 20 mM Tris 
(hydroxymethyl) amino methane, 1 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride, 
1 mM dithiothreitol, 0.9% cholate, 75 mM sucrose, 5 mM MgC12, pH 8.0. The mutant 
receptors were named using the one letter code for amino acids, where D69N stands for 
the mutation of aspartate residue 69 to asparagine. D97-103N has aspartate residues 97 
and 103 changed to asparagine residues. 
Materials 
All radioligands were purchased from DuPont-New England Nuclear. Specific 
activities were 41.9 Ci/mmol for [3H] L-QNB, 80.4 Ci/mmol for [3H] NMS and 87.5 
Ci/mmol for [3H] Oxo M. Unlabeled Oxo M was obtained from Research Biochemicals 
Inc., and carbachol was purchased from Aldrich Chemical Company. 
All buffers were purchased from Sigma except Hepes which was from Research 
Organics, Inc. All other reagents were also from Sigma with the exception of MgC12 
from Mallinckrodt, Inc. and sucrose from United States Biochemical Corp. 71 
Membrane preparation 
CHO cells expressing the recombinant pm2 muscarinic receptor were used as a 
source and membranes were prepared as described for porcine atrial membranes 
(Peterson & Schimerlik, 1984). Prepared membranes were frozen at -80°C in buffer A. 
Site-directed mutants were supplied by Walter K. Vogel (D69N, D97N, D69-97N, 
D97-103N) and Dr. David J. Broderick (D103E, D103C). The mutants were produced 
according to the method of Kunkel et al. (1987) and stably expressed in CHO cells. In 
the case of the mutants D69N, D97N, D69-97N and D97-103N membranes were 
prepared and stored at -80°C. Cells containing the mutant receptors D103E and D103C 
were homogenized on ice with ten strokes using a Potter-Elvehjem homogenizer with 
teflon pestle, and the homogenates were used in binding experiments. 
In some cases membranes containing the wild-type pm2 muscarinic receptor were 
reconstituted with purified G-proteins in buffer D as described in Chapter II. 
Ligand binding 
Ligand binding experiments were performed as described in Chapter II except that 
membranes/homogenized cells were diluted into buffer B instead of buffer A. Buffer B 
contained 10 mM sodium acetate, 10 mM 3-(N-Morpholino) propane sulfonic acid 
(MOPS), 10 mM 4-(2-hydroxyethyl)-1-piperazine ethane sulfonate (Hepes), 5 mM 
MgC12, 1 mM EDTA and 1 mM EGTA and was adjusted to the pH specified. This buffer 
system was chosen to minimize differences in ionic strength over the range pH 4-9. 72 
Data analysis 
Ligand binding data were analyzed as described in Chapter II, and the obtained 
dissociation constant were converted to their negative logarithm and plotted versus the 
pH. The dependence of the p(KD)App on the pH was fit assuming that protonation of one 
residue on the receptor results in complete loss of ligand binding. This model can be 
described as follows: 
H+ 
KD
A ++ R- N---=`- RA 
KA 
where R is the receptor, A the ligand and KD and KA are the dissociation constants 
governing ligand binding and protonation, respectively. 
The fractional saturation of the receptor with ligand, Y, is given by 
[L] 
Y _ 
KD 
[L]  [H] 1 +  + 
KD  KA 
Thus the apparent dissociation constant of the ligand is 
(KD)App  KD (1 +  )  (Equation 1)
KA 
Results from pH dependence studies are fit to this equation using a nonlinear least 
squares fitting routine described by Duggleby (1984). 73 
RESULTS 
First, the pH dependence of binding of two antagonists was tested. Figure 3.1 
shows the binding of the quaternary amine NMS at pH 7.0 and 4.5 to CHO cell 
membranes reconstituted with purified G-proteins. At both pH values NMS binding was 
saturable and was corrected for nonspecific binding. The amount of bound radioligand 
was normalized as percent saturation to account for different receptor concentrations in 
the two experiments. At pH 4.5 the binding curve was right-shifted by a little over one 
order of magnitude. Figure 3.2 shows Scatchard plots of the two binding curves. Over a 
concentration range of two orders of magnitude the Scatchard plots gave straight lines 
indicating that for both pH values binding was noncooperative and to a homogeneous 
population of sites. The dissociation constants obtained from direct binding experiments 
with the radioligand [3H] NMS are plotted versus the pH in Figure 3.3. Thus each point 
in this figure represents a separate experiment. All binding experiments were performed 
in the same buffer system as described under 'Materials and Methods' to minimize 
variations in the ionic strength of the buffer. Specific binding was stable at pH 6-8.5. At 
low pH (<5.0) approximately 40% of specific binding was lost irreversibly, but since 
complete binding curves were obtained and analyzed for each pH value and binding was 
allowed to equilibrate, this loss does not cause errors in the pH dependence. At pH 
values below 5.5 the affinity of the receptor for NMS is decreased, and the data was fit 
assuming that protonation of one specific residue on the receptor results in complete loss 
of ligand binding. The equation describing this model is derived under 'Materials and 
Methods'. The pKA that was obtained for the residue involved in NMS binding was 5.45 
± 0.14. This result was in good agreement with the values of 5.5 and 5.9 measured by 
Ehlert & De len (1990) and Birdsall et al. (1989). 
The other antagonist examined was the tertiary amine L-quinuclidinyl benzilate (L­
QNB). Direct binding of the radiolabeled drug [3f1] L-QNB to membranes reconstituted 74 
with G-proteins at pH 5.0 and 4.5 is shown in Figure 3.4. As with NMS, specific binding 
of [3f1] L-QNB was saturable and binding curves were normalized to % saturation with 
the radioligand. At low pH the binding curve was right-shifted. Scatchard plots of the 
direct binding data are illustrated in Figure 3.5 to show that at both pH values binding of 
[3H] L-QNB agreed with the law of mass action for binding to a single class of sites. 
Figure 3.6 shows the pH dependence of the dissociation constant of L-QNB. The 
receptor's affinity for the ligand was reduced below pH 5.5, and the line represents a 
nonlinear least squares fit of the data to Equation 1. Over the pH range studied the 
tertiary amine nitrogen of L-QNB should be protonated, although it is possible that the 
slight decrease in binding affinity at pH values greater than 7 is due to deprotonation of 
the ligand. The pKA value obtained was 5.39 ± 0.17. 
Next, the pH dependence of binding of two agonists was examined. As discussed in 
Chapter II, agonist binding takes place over a concentration range of 5-6 orders of 
magnitude. In order to measure complete binding curves, the radiolabeled antagonist 
[3H] L-QNB was used as a tracer and displaced by increasing concentrations of the 
agonist. This method and the fitting of the data to three independent classes of binding 
sites is discussed in detail in Chapter II. Membranes reconstituted with purified G-
proteins are used in the experiments illustrated in Figure 3.7. The two curves show the 
displacement of the tracer by increasing concentrations of the quaternary amine carbachol 
at pH 7.5 and 5.5. While the shape of the curves is similar, the binding isotherm is right-
shifted at lower pH. The same experiment was repeated at a number of pH values, and 
the set of experiments was evaluated with respect to the fractions of receptor in the 
different classes of agonist binding sites. No trends were observed, and suitable fractions 
were chosen and fixed in the following separate analysis of the binding curves. The 
dissociation constants obtained for the superhigh, high and low affinity binding sites are 
plotted versus the pH in Figure 3.8. Panel D shows the pH dependence of carbachol 
binding to the low affinity class of sites obtained from a second set of experiments. Only 75 
two classes of binding sites were needed to fit this set of experiments, and the 
dissociation constants of the high affinity class were too poorly determined to give a 
meaningful pH dependence. Although the apparent KD values obtained from the second 
set of experiments are somewhat smaller, the pH dependence is very similar. Nonlinear 
least squares fitting to Equation 1 gave pKA values of 6.52 ± 0.20 for the lowest affinity 
class of sites in the first set and 6.71 ± 0.16 for the second set. The superhigh and high 
affinity classes show .a decrease in binding at a pH greater than 7.5. It is possible that this 
decrease was an artefact in the data fitting caused by conversion of binding sites to the 
low affinity state. This phenomenon was previously observed by Asselin et al. (1983) for 
rat heart membranes. For this reason dissociation constants at pH 8.0 and 8.5 were left 
out during the analysis of superhigh and high affinity carbachol binding, although the 
data points are included in panels A and B. The pKAs obtained for the superhigh and 
high affinity classes of sites were 6.84 ± 0.06 and 6.61 ± 0.08 respectively. Binding of 
the second agonist, Oxo M, is analyzed in very much the same way and is illustrated in 
Figures 3.9 and 3.10. Like carbachol Oxo M contains a quaternary ammonium group. 
Binding to reconstituted membranes at pH 7.5 and 5.5 is shown in Figure 3.9, and binding 
over the whole pH range examined is illustrated in Figure 3.10 for each class of binding 
sites separately. pKAs were 6.53 ± 0.12, 6.67 ± 0.08 and 6.84 ± 0.04 for superhigh, high 
and low affinity binding, respectively. Since Oxo M could be obtained radioactively 
labeled, it was possible to directly measure binding to the superhigh affinity class of sites 
as shown in Figure 3.11 for pH 7.5 and 5.5. Figure 3.12 shows Scatchard plots of the 
data, indicating that binding of the radioligand was indeed saturable and obeyed the law 
of mass action. The pH dependence obtained from the direct binding experiments is 
shown in panel D of Figure 3.10 for comparison with data obtained from displacement 
studies. The observed pKA was 6.40 ± 0.22. Since the two agonists and the two 
antagonists gave essentially the same results, as will be discussed later, in the following 
studies only one antagonist (NMS) and one agonist (carbachol) were used. 76 
To control for possible effects of the reconstitution procedure, NMS and carbachol 
binding was examined in nonreconstituted (native) membranes. Carbachol binding to 
these membranes determined by displacement of L-QNB showed only high and low 
affinity sites, and the pH dependence of binding to these sites was identical to the one 
obtained with reconstituted membranes. In contrast NMS binding at low pH was much 
more stable in native membranes than in reconstituted preparations. Figure 3.13 shows 
the pH dependence of NMS binding to native membranes. At pH 4.0 the affinity for the 
ligand was decreased by less than one order of magnitude, whereas [3H] NMS binding to 
reconstituted membranes was barely detectable at pH 4.0 (Figure 3.3). The pKA 
determined for NMS binding to native membranes was 4.50 ± 0.08one pH unit less 
than what was found for reconstituted membranes. One would not expect G-proteins to 
greatly affect antagonist binding, thus it seemed more likely that the shift in pKA was due 
to the reconstitution procedure itself rather than an action of the G-protein. Indeed, when 
membranes were subjected to a reconstitution procedure substituting buffer D for G-
proteins in the same buffer, the treated membranes showed the same pH dependence of 
NMS binding as the reconstituted membranes. A plot of the negative logarithm of the 
dissociation constants is shown in Figure 3.14. The pKA obtained (5.44 ± 0.13) was 
indistinguishable from the pKA seen with membranes reconstituted in the presence of G-
proteins (5.45 ± 0.14). For the following pH dependence studies only nonreconstituted 
membranes were used. 
The second part of this study attempted to identify the amino acid residues on the 
pm2 receptor that give rise to the observed pKA values. Likely candidates are pointed out 
in the introduction. These residues, namely aspartates 103, 69, 97 and 120, were changed 
to asparagines by site-directed mutagenesis. The mutants D103N and D120N were either 
not expressed or showed no detectable ligand binding. This points to an important role of 
these two residues, although it is possible that the mutation interfered with stable 
expression independent of ligand binding, e.g. by making the receptor more susceptible to 77 
proteolysis. Fortunately, information about the aspartate residue 103 could be obtained 
from the double-mutant D97-103N, that was expressed and showed saturable ligand 
binding. 
Another double-mutant, D69-97N, was the first mutant used in pH dependence 
studies. Figure 3.15 shows direct binding of the radiolabeled antagonist [3H] NMS to 
native membranes of CHO cells expressing this mutant receptor. Binding was saturable 
and gave rise to hyperbolic isotherms at all pH values studied. A plot of the negative 
logarithm of the obtained dissociation constants versus the pH is shown in Figure 3.16. 
Nonlinear least squares fitting to Equation 1 yielded a pKA of 4.26 ± 0.05. Values for the 
two single mutants D69N and D97N were 4.54 ± 0.10 and 4.43 ± 0.03, respectively. 
Data are not shown here. The double-mutant D69-97N shows mostly low affinity 
binding of the agonist carbachol. Carbachol displacement of the tracer [3H] L-QNB at pH 
7.5 and 5.5 is shown in Figure 3.17. The experiment was repeated at a number of pH 
values, and the dissociation constants obtained for the low affinity class of binding sites 
are plotted versus the pH in Figure 3.18. The curve yielded a pKA of 6.70 ± 0.18 for low 
affinity carbachol binding to the double- mutant. Since this value was identical with 
results obtained for the wild-type receptor, the single mutants were not examined 
separately. Since the membranes containing the double-mutant were not reconstituted, 
this also confirms that agonist binding is not affected by the reconstitution procedure 
outside of a change of the fractions with different affinities. 
To examine the role of aspartate 103 ligand binding to the double-mutant D97-103N 
was studied. Incubation of the mutant with 10 nM [3H] Oxo M, equivalent to 10 times 
the wild-type dissociation constant, failed to yield any detectable radioligand binding. 
Also 1 mM carbachol was ineffective in displacing L-QNB from the mutant receptor at 
L-QNB concentrations close to its dissociation constant. Thus, the double-mutant D97­
103N does not seem to have significant affinity for agonists. The affinity for antagonist 
is also reducedby about 50-fold for N-methylscopolamine, but is still measurable. 78 
Figure 3.19 shows the pH dependence of NMS binding to the double-mutant D97-103N. 
Nonlinear least squares fitting of the data to Equation 1 yielded a pKA of 5.64 ± 0.17. 
The membranes containing the mutant receptor were not reconstituted, although the high 
pKA is in the range of values obtained with reconstituted preparations. The aspartate to 
glutamate and aspartate to cysteine mutants D103E and D103C also showed no 
displacement of 15 nM [3H] L-QNB with Oxo M or acetylcholine at concentrations up to 
1 mM. Antagonist affinity was reduced similarly to the double-mutant D97-103N. 
However, since these mutants were expressed at lower levels, it was not possible to 
obtain meaningful pH dependences. 79 
DISCUSSION
 
Tables 3.1 and 3.2 summarize the pKA values obtained with wild-type and mutant 
pm2 muscarinic receptors. The data were grouped into antagonist pKAs in Table 3.1 and 
agonist pKAs presented in Table 3.2. The two antagonists examined, NMS and L-QNB 
showed the same pH dependence of binding to CHO cells reconstituted with purified G-
proteins. Within the error, the pKA values were identical and in good agreement with the 
value published for NMS binding. Without undergoing a reconstitution procedure native 
membranes were less sensitive to low pH, and NMS binding to native membranes was 
governed by a pKA one pH unit less than that seen with reconstituted membranes. This 
shift in pKA was independent of whether G-proteins were added during the reconstitution 
and was most likely due to the detergent treatment of the membranes. During the 
reconstitution process membranes were incubated with 0.6% cholate. This concentration 
of detergent could alter the pH dependence of ligand binding by changing the 
conformation of the receptor or by changing the lipid environment immediately adjacent 
to the receptor. In the first case a conformational change of the receptor could either 
change that residue(s) with which the ligands interact, or change the pKA of a given 
residue. The alternative explanation of changing the lipid environment is supported by 
indications of a role of phospholipids in binding of muscarinic antagonists (Aronstam et 
al., 1977). It was found that acidic phospholipids enhance the binding of L-QNB, and 
that L-QNB binding in turn was decreased by pretreatment of the membranes with 
phospholipases. The authors suggested that phospholipids associated with the muscarinic 
receptor may provide accessory hydrophobic binding areasa concept proposed by 
Ariens and Simonis (1967). 
Membranes from CHO cells expressing the mutant receptors were not subjected to 
detergent treatment. NMS binding to the mutant receptors D69N and D97N and to the 
double-mutant D69-97N showed the same pH dependence as binding to wild-type 80 
receptors in a nonreconstituted system. Thus, at least in native membranes, NMS binding 
seems to involve neither aspartate 69 nor aspartate 97. This finding is supported by the 
high affinity of these mutants for the antagonist. 
In contrast, the double-mutant D97-103N shows reduced affinity for both NMS and 
L-QNB. In addition, the pKA for NMS binding to this mutant was shifted by roughly one 
pH unit. It was very similar to the pKA values obtained for antagonist binding to 
reconstituted membranes containing the wild-type receptor. This might indicate that the 
double-mutant D97-103N is locked into a similar conformation as the detergent-treated 
wild-type receptor or has the same phospholipid environment. The latter case seems 
unlikely since both mutations are located within the central pore of the receptor. 
Aspartate 103 cannot be the residue giving rise to the pKA of 5.4, since this pKA was seen 
in D97-103N. The pKA of 4.4 also cannot be associated with aspartate 103. If aspartate 
103 had a pKA value of 4.4 and the mutation D97-103N forced ligand binding to a less 
preferred residue with a pKA of 5.6, reconstitution of CHO cell membranes with G-
proteins should also lower ligand affinity, which was not observed. 
In summary pKAs governing antagonist binding fall into two groups: a group 
around 4.4 for native membranes and a group around 5.4 for reconstituted membranes. 
Protonation of the aspartates 69, 97 and 103 did not seem to affect antagonist binding. 
As seen in Table 3.2 only one pKA around 6.6 was observed in agonist binding 
studies. This pKA was seen with both agonists tested, carbachol and Oxo M, and 
described binding to all three classes of sites. This value was significantly higher than 
any of the pKAs observed with antagonists and was also unaffected by reconstitution of 
the membranes. This indicated that a different residue was involved in charge-charge 
interactions with antagonists than with agonists. The superhigh and high affinity classes 
of sites showed a decrease in agonist binding at a pH greater than 7.0. This was not due 
to a change in the ligand, since both agonists tested were quaternary amines. However, it 
might be an effect on the fractions of binding sites showing superhigh and high affinity 81 
binding rather than on the dissociation constants. The decrease was more pronounced for 
carbachol than for Oxo M. Whether the fractions or the dissociation constants were 
affected, the change in binding had to be due to the deprotonation of a residue at an 
allosteric site. 
Mutating aspartate residues 69 and 97 to asparagines had no effect on the pH 
dependence of carbachol binding, indicating that neither residue is involved in ionic 
interactions with the agonist's headgroup. The demonstrated necessity of aspartate 103 
for agonist binding indicates that it may be the residue with the pKA of 6.6. Since agonist 
binding is completely abolished in any mutant involving aspartate 103, this hypothesis 
cannot be tested directly. 
To end this discussion with a little speculation, the presented results are in 
agreement with ionic interactions with aspartate 103 being the major force in agonist 
binding and antagonist binding to the same site being controlled mostly by hydrophobic 
forces. In this model the two pKAs observed in antagonist binding studies are due to the 
protonation of an allosteric site resulting in loss of ligand binding. The allosteric residue 
may very well be aspartate 120. Since aspartate 120 is located at the interface of the cell 
membrane and the cytoplasm, it is expected to have a lower pKA value than residues 
buried in the hydrophobic core of the protein. A conformational change caused either by 
detergent treatment or by the mutation D97-103N then results in a shift of the pKA of the 
allosteric residue. Small conformational changes can conceivably cause rather large pKA 
shifts of residues located at the membrane interfaces. 82 
Figure 3.1  [3H1 NMS binding to reconstituted membranes at pH 4.5 and 7.0. 
The binding experiment was performed as described in Chapter IV. CHO 
cell membranes reconstituted with G-proteins were diluted into buffer B 
adjusted to the given pH. The final binding site concentration was 
approximately 1.6 nM. Membranes were incubated with concentrations of 
[3H] NMS between 40 pM and 100 nM for 1 hour at 25°C. Bound and free 
radioligand were separated by filtration through Whatman GF/B filters 
pretreated with 0.1% polyethylene imine. Bound ligand was normalized to 
100% at saturation, and the curve through the data was calculated using the 
fitted parameters (KD)APP = 51 nM at pH 4.5 and (KD)Api, = 2.2 nM at pH 7.0 
from Figure 3.2. I  1 1 I I  i  I  I i  I 1 1 11 
pH 7.0 
,  i 
0.1  1  10  100 
Figure 3.1  [[H3]NMS] (nM) 84 
Figure 3.2	  Scatchard analysis of [3H1NMS binding to reconstituted membranes. 
Data from Figure 3.2 were plotted as bound ligand/free ligand versus bound 
ligand as described by Scatchard (1949). This transformation was used to 
assure that binding took place to a homogeneous population of sites. It also 
allows fitting the data by linear regression and yielded the apparent 
dissociation constants (KD)APP = (51 ± 6) nM at pH 4.5 and (KD)App = (2.2 ± 
0.3) nM at pH 7.0. 85 
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Figure 3.3  pH dependence of the dissociation constant of NMS in reconstituted 
membranes. 
Data points in this plot represent separate binding experiments, two of which 
are shown in Figure 3.1. The dissociation constants obtained from these 
experiments were converted to the negative logarithm and plotted versus the 
pH. The line represents a fit of the data to Equation 1 with pKA = 5.45 ± 
0.14 and KD = (2.0 ± 0.3) nM. 9.5 
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Figure 3.4  Binding of [3H] L-QNB to reconstituted membranes at pH 4.5 and 5.0. 
The binding experiment was performed as described in Chapter IV, except 
that reconstituted membranes were diluted into buffer B adjusted to pH 5.0 
and 4.5, respectively. Final binding site concentrations were 1.8 nM at 
pH 5.0 and 1.6 nM at pH 4.5. Bound ligand was normalized to 100% at 
saturation, and the curve through the data was calculated using the fitted 
parameters from Figure 3.5 (KD)App = 86.4 nM at pH 4.5 and (KD)App = 1.8 
nM at pH 5.0. Figure 3.4  [[H3]L-QNB] (nM) 90 
Figure 3.5	  Scatchard analysis of [3H] L-QNB binding to reconstituted membranes. 
Data from Figure 3.4 were plotted according to Scatchard (1949). The lines 
represent a fit of the data by linear regression yielding (KD)App = (6.4 ± 0.4) 
nM at pH 4.5 and (KD)APP = (1.8 ± 0.) nM at pH 5.0. 91 
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Figure 3.6	  pH dependence of the dissociation constant of L-QNB in reconstituted 
membranes. 
Each data point represents a separate experiment. Data points at pH 4.5 and 
5.0 were obtained from the direct binding experiments shown in Figure 3.4. 
All other data points were obtained from the analysis of displacement 
studies using [3H] L-QNB as a tracer. Displacement studies and their 
analysis are described in detail in Chapter II. All data points were fit to 
Equation 1 as shown by the solid line. Fitted data were pKA = 5.39 ± 0.17 
and KD = (98 ± 8) pM. 4
 94 
Figure 3.7	  Carbachol binding to reconstituted membranes at pH 5.5 and 7.5. 
The binding curves were obtained by a displacement study using 150 pM 
[3H] L-QNB as a tracer as described in Chapter II. Binding site 
concentrations in the assay were approximately 100 pM. Plotted is the 
fractional saturation of the receptor with [3H] L-QNB normalized to 1 in the 
absence of carbachol. The lines represent a nonlinear least squares fit of the 
data to a model assuming three independent classes of binding sites (pH 5.5: 
K = 191 pM, F1 = 0.33, F2 = 0.4, K1 = 37 nM, K2= 2.6 RM, K3 =53011M; 
pH 7.5: K = 124 pM, F1 = 0.33, F2 = 0.4, Ki = 5.3 nM, K2 -= 0.17 p.M, K3= 
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Figure 3.8	  pH dependence of the dissociation constants of carbachol in reconstituted 
membranes. 
Dissociation constants obtained from displacement studies including the 
ones shown in Figure 3.7 were converted to the negative logarithm and 
plotted versus the pH. Panels A, B and C show the pH dependence for the 
superhigh, high and low affinity classes of sites found in one set of 
experiments. The data obtained for the low affinity class of sites in a second 
set of experiments is illustrated in panel D.  All data were fit to Equation 1. 
Fitted parameters were panel A: pKA = 6.84 ± 0.06 and KD fixed at 5 nM; 
panel B: pKA = 6.61 ± 0.08, KD fixed at 0.15 gM; panel C: pKA = 6.52 ± 
0.20, KD = (46 ± 16)11M; panel D: pKA = 6.71 ± 0.16, KD = (20 ±  6) ti.M. 
Data points at pH 8.0 and 8.5 in panels B and C were omitted during the 
fitting as discussed in the text. 5.0 
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Figure 3.9	  Oxo M binding to reconstituted membranes at pH 5.5 and 7.5. 
CHO cell membrane reconstituted with G-proteins were diluted into buffer 
B at pH 5.5 and 7.5 to give final binding site concentrations of 70 pM. 
150 pM [3H] L-QNB were displaced by increasing concentrations of Oxo M. 
Plotted is the fractional saturation of the receptor with [3H] L-QNB 
normalized to 1 in the absence of Oxo M. The data were fit assuming three 
independent classes of sites (pH 5.5: K = 161 pM, F1 = 0.4, F2 = 0.4, K1= 
4.6 nM, K2 = 3.6 0/1, K3 undetermined; pH 7.5: K = 81 pM, F1 = 0.4, F2 = 
0.4, K1 = 0.5 nM, K2 = 0.2  K3 = 9.5 p.M). III 1 1111  I  1 II 1 1 1 I  I "MI  I  I "WI  I  'III  1  I "  I  I "MT 
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Figure 3.10 pH dependence of the dissociation constants of Oxo M in reconstituted 
membranes. 
Dissociation constants obtained from a set of displacement studies as 
illustrated in Figure 3.9 are shown as a function of pH. Panels A, B and C 
represent the superhigh, high and low affinity classes of sites, respectively. 
Panel D shows the pH dependence of [3H] Oxo M binding to the superhigh 
affinity class of sites as determined by direct binding experiments illustrated 
in Figure 3.11. All data were fit to Equation 1 (panel A: pKA = 6.53 ± 0.12, 
KD = 0.42 ± 0.09 nM; panel B: pKA = 6.67 ± 0.06, KD = 0.191.1M fixed; 
panel C: pKA = 6.84 ± 0.04, KD fixed at 9 I.LM; panel D: pKA = 6.40 ± 0.22, 
KD = 0.81 ± 0.11 nM). 9.8 
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Figure 3.11 Binding of [3H] Oxo M to the superhigh affinity class of sites in 
reconstituted membranes at pH 5.5 and 7.5. 
Binding experiments were performed as described in Chapter IV, except that 
reconstituted membranes were diluted into buffer B at pH 5.5 and 7.5 to give 
final binding site concentrations of approximately 2 nM. Membranes were 
incubated with [3H] Oxo M concentrations between 40 pM and 10 nM for 1 
hour at 25°C. Bound ligand was normalized to 100% at saturation, and the 
curve through the data was calculated using the fitted parameters from 
Figure 3.12 ((KD)App = 165 pM at pH 5.5 and (KD)App = 0.69 nM at pH 7.5). c* " 
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Figure 3.12 Scatchard analysis of [3H] Oxo M binding to the superhigh affinity class of 
sites in reconstituted membranes. 
Binding data from Figure 3.11 were plotted according to Scatchard (1949). 
The good agreement of the data with the fitted line obtained by linear 
regression shows that at the concentrations used binding was only detected 
to the superhigh affinity class of binding sites.  Fitted parameters were 
(KD)APP = (1.6 ± 0.2) nM at pH 5.5 and (KD)APP = (0.69 ± 0.07) nM at pH 
7.5. 105 
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Figure 3.13 pH dependence of NMS binding to native membranes. 
Membranes not subjected to a reconstitution procedure were diluted into 
buffer B at different pH values to yield final receptor concentrations around 
1 nM. Direct binding of [3H] NMS was measured as described in Chapter 
IV, and the negative logarithm of the obtained dissociation constants was 
plotted versus the pH. Data were fit to Equation 1 yielding pKA = 4.50 ± 
0.08 and KD = (6.3 ± 0.6) nM. 9.0 
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Figure 3.14 pH dependence of NMS binding to membranes reconstituted in the absence 
of G-proteins. 
CHO cell membranes were subjected to a reconstitution procedure as 
described in Chapter II except that G-proteins in buffer D were replaced 
with buffer D alone. The membranes were then diluted into buffer B at 
various pH values to give receptor concentrations around 1 nM and used in 
binding experiments with NMS. The obtained dissociation constants are 
shown as a function of pH together with a fit of the data to Equation 1 with 
pKA = 5.44 ± 0.13 and KD = (1.4 ± 0.2) nM. 9.5'  I  I  I 
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Figure 3.15 Binding of [3H] NMS to the double-mutant D69-97N at pH 4.5 and 7.5. 
CHO cell membranes containing the mutant receptor D69-97N were diluted 
into buffer B at pH 4.5 and 7.5 to a final receptor concentration of 2 nM. 
Direct binding of [3H] NMS was measured as described in Chapter IV. Data 
were transformed according to Scatchard (1949) and fit by linear regression 
yielding*(KD)App = (5.13 ± 0.35) nM at pH 4.5 and (KD)App = (3.66 ± 0.19) 
nM at pH 7.5. i  I  1  11111  I  1  I  11111 
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Figure 3.16 pH dependence of NMS binding to D69-97N. 
Dissociation constants obtained from the binding experiments illustrated in 
Figure 3.15 were converted to the negative logarithm and plotted versus the 
pH. Data were fit to Equation 1 yielding pKA = 4.26 ± 0.05 and KD = (3.5 ± 
0.4) nM. 4 5  7 8 
Figure 3.16 
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Figure 3.17 Carbachol binding to the double-mutant D69-97N of pH 5.5 and 7.5. 
Binding of carbachol to the mutant receptor D69-97N was examined in 
displacement studies using the tracer [3H) L-QNB. Binding site 
concentrations were 90 pM and 70 pM in buffer B at pH 7.5 and 5.5, 
respectively. The data were analyzed assuming two independent classes of 
binding sites as described in Chapter H (pH 5.5: K = 55 pM, F1 = 0, F2 =  1, 
K2 = (98 ± 7)11M; pH 7.5: K = 29 pM, F1 = 0.19 ± 0.04, F2 = 0.81 ±0.04, 
K1= (0.90 ± 0.61) uM, K2 = (29 ± ......  at  smiNima ill ---1v-rn-rrr 1.2  .  1 111111
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Figure 3.18 pH dependence of carbachol binding to D69-97N. 
Dissociation constants for the low affinity class of binding sites obtained 
from displacement studies are plotted as a function of pH. The line 
represents a nonlinear least squares fit of the data to Equation 1 with pKA = 
6.70 ± 0.18 and KD = (17 ± 2) gM. I  I  I  1 . I . I . I 
5.5  6.0  6.5  7.0  7.5  8.0  8.5 
Figure 3.18  pH 118 
Figure 3.19 pH dependence of NMS binding to the double-mutant D97-103N. 
CHO cell membranes containing the double-mutant D97-103N were diluted 
into buffer B at various pH values to yield final receptor concentrations of 
40 nM. [3H] NMS binding was measured as described in Chapter IV. 
Fitting of p(KD)App versus pH to Equation 1 yielded pKA = 5.64 ± 0.17 and 
KD=(64 ± 11) nM. 7.5 
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Table 3.1	  Summary of pKAs governing antagonist binding. 
The pKAs listed for the specified type of receptor and type of ligand in the 
presence or absence of reconstitution with purified G-proteins was obtained 
by performing direct binding experiments over a pH range from 4.0 to 8.5 
and fitting the obtained dissociation constants to Equation 1. The receptor 
concentration in the binding assay was approximately 1 nM. Receptor 
Wild-type 
Wild-type 
Wild-type 
Wild-type
 
D69-96N
 
D69N
 
D97N
 
D97-103N
 
Table 3.1 
Reconstitution 
yes
 
yes
 
yes, in absence of
 
G-protein
 
no
 
no
 
no
 
no
 
no
 
Ligand 
NMS
 
L-QNB
 
NMS
 
NMS 
NMS 
NMS 
NMS 
NMS 
pKA 
±S D 
5.45±0.14 
5.39±0.17 
5.44±0.13 
4.50±0.08 
4.26±0.05 
4.54±0.10 
4.43±0.03 
5.64±0.17 122 
Table 3.2	  Summary of pKAs governing agonist binding. 
The table summarizes the pKAs obtained with the agonists carbachol and 
Oxo M. Displacement studies, illustrated in Figures 3.7 and 3.9, were 
performed to obtain dissociation constants at different pH values, which 
were then fit to Equation 1 to yield the listed pKA.  The third row shows the 
result of the direct binding experiments with [3H] Oxo M shown in Figure 
3.11. Receptor 
Wild-type 
Wild-type 
Wild-type 
Wild-type 
D69-97N 
Table 3.2 
Reconstitution 
yes 
yes 
yes 
yes 
no 
Ligand 
Carbachol 
Carbachol
 
Oxo M
 
Oxo M
 
Carbachol 
Class of sites 
Fi 
F2 
F3 
F3 
F1 
F1 
F2 
F3 
F3 
pKA 
±SD 
6.84±0.06 
6.61±0.08 
6.52±0.20 
6.71±0.16 
6.40±0.22 
6.53±0.12 
6.67±0.08 
6.84±0.04 
6.70±0.18 124 
CHAPTER IV
 
KINETICS OF OXOTREMORINE M BINDING TO THE
 
SUPERHIGH AFFINITY CLASS OF SITES
 
INTRODUCTION 
Agonist binding to muscarinic receptors has mostly been examined in competition 
binding studies using radiolabeled antagonists as tracers. Data obtained in this way have 
to be fit employing nonlinear least squares fitting routines. The equation fit necessarily 
contains the investigators bias about the mechanism of binding. For example the same 
data set can be fit assuming three independent classes of receptor binding sites or a 
ternary complex model involving a second protein that interacts with the muscarinic 
receptor. In some cases the data will fit to both models equally well, but the parameters 
that are obtained from the two fits are different and have completely different physical 
meaning. For the three-site model, three parameters specific for the ligand and two 
parameters specific for the membrane preparation are obtained, i.e. the three dissociation 
constants and the fraction of sites in each class. The ternary complex model contains two 
ligand-specific parameters (the dissociation constant and the factor by which the 
modulating protein influences ligand binding) and two preparation-dependent parameters 
(the concentration and the affinity of the modulating protein). Obviously, the uncertainty 
about the right binding model poses a major problem in interpreting any competition 
binding data. But even if oneas currently the majority of researchers dofits binding 
data to the three-site model, data analysis is not unambiguous. Most binding curves do 
not show marked inflections. This is in agreement with dissociation constants separated 
by less than two orders of magnitude, but it allows for more than one set of parameters to 
fit the data. Changes in the fractions of sites in each class can be compensated by 
changes in dissociation constants to give essentially the same fitted curve. 125 
Considering these problems, it is advantageous to directly measure agonist binding 
where possible, and to try to obtain information on the mechanism of binding. The 
discovery of the potent muscarinic agonist oxotremorine M has made this methodology 
available, since radiolabeled oxotremorine M is now commercially available and binds 
with high affinity to a saturable class of sites. The fraction of muscarinic antagonist sites 
that bind [3H] oxotremorine M with high affinity varies in different membrane 
preparations and corresponds to the highest affinity class of sites in the three-site model. 
As shown in Chapter II, this is the class of sites that is sensitive to guanine nucleotides. 
Therefore aside from ligand binding per se, [3H] oxotremorine M binding might also 
reveal information about receptor G-protein interactions. 
Several researchers have undertaken binding studies using [3H] oxotremorine M. 
The dissociation constants obtained for the highest affinity site are generally in good 
agreement and range from 300 pM in rat heart at 4°C (Harden et al., 1983) to 6.5 nM at 
25°C for rat heart and cortex (Gil lard et al., 1987). Association and dissociation kinetics 
were also measured (Harden et al., 1983 and Gil lard et al., 1987), but these measurements 
were mostly used to support equilibrium binding data and were not designed to look in 
detail at the binding mechanism. The association kinetics were measured at only one 
ligand concentration, which means that the reported rate relies on the assumption that 
binding occurs in a single reversible step. Since the obtained kinetic data agreed with 
equilibrium binding measurements, there was no reason to look for a more complicated 
binding mechanism. Although in rat heart Gil lard et al. found biphasic association and 
dissociation rates, they could be explained by two receptor populations with the same 
affinity for [3H] oxotremorine M but different kinetics. Schimerlik (unpublished 
observations) obtained similar results using the antagonist [3H] L-quinuclidinyl benzilate 
and membranes from Chinese hamster ovary cells overexpressing the m2 muscarinic 
receptor. On the other hand when porcine atria was used the results were more complex 
(Schimerlik & Searles, 1980). Measuring [3H] L-quinuclidinyl benzilate dissociation two 126 
exponentials were observed, but the amplitudes of the two phases were dependent on the 
concentration of the competing ligand. At very high concentrations of the competing 
ligand only a single phase was observed. At low concentrations of competing ligand 
dissociation was also monophasic but showed a 16-fold greater relaxation time. In 
between two phases were observed with the same slow and fast relaxation times, and the 
amplitudes of the two phases were a function of the competing ligand concentration. At 
the time it was concluded that the competing ligand either binds to an allosteric site on 
the receptor or alters the properties of the membrane preparation. 
Similarly complex kinetic behavior has been observed with other G-protein coupled 
receptors. Results obtained with glucagon and histamine receptors may serve as an 
example for the kinds of complex phenomena that occur and might also be related to the 
experiments discussed in this chapter. Bharucha and Tager (1990) studied interactions of 
glucagon with the canine hepatic glucagon receptor and in addition to fast and slow 
association and dissociation phases found a component of irreversably bound ligand. 
This component was only present at higher temperatures. From these studies it was 
concluded that two non-interacting populations of sites were present giving rise to the 
slow and fast association and dissociation phases and that a fraction of each population 
can be converted to nondissociable sites in a subsequent step. However, not all of the 
observations agree with this fairly simple model. The formation of irreversibly bound 
ligand is found to be a first-order reaction rather than a zero-order reaction, and the 
fraction of ligand that becomes irreversibly bound is a function of ligand concentration. 
In addition, the biological significance of the formation of nondissociable receptor­
ligand-complexes is unclear, although it has been demonstrated for a number of receptors. 
Sinkins et al. (1983) studied histamine binding to membranes from guinea pig 
cerebral cortex. It is unclear whether their preparation contains H2 or H3 histamine 
receptors or a mixture of both, but receptor heterogeneity is clearly insufficient to explain 
all of the observations. Two classes of sites are needed to fit the equilibrium binding 127 
data, and association and dissociation kinetics are biexponential. However, the 
amplitudes of the two phases in the association and dissociation measurements are not the 
same and also do not correspond to the fractions found in equilibrium binding studies. 
Further, the fractions corresponding to the two dissociation constants are different for 
different ligandsboth agonists and antagonists. Sinkins et al. end the summary of their 
paper saying that the difficulty in interpreting equilibrium binding data "may reflect the 
failure to assess binding in the correct mechanistic context". 
Similar problems with equilibrium binding data in this laboratory are the reason 
why detailed kinetic studies were initiated using the tritium-labeled agonist oxotremorine 
M. Association of oxotremorine M was measured as a function of ligand concentration, 
and the effect of different experimental protocols on oxotremorine M dissociation was 
examined. A presentation of the results is followed by a discussion of different binding 
models in an attempt to better understand the mechanistics of oxotremorine M binding. 
Hopefully, the discussion presented here will in some form be applicable to other 
muscarinic ligands as well as to other G-protein coupled receptors. 128 
MATERIALS AND METHODS 
Abbreviations 
CHO cells, Chinese hamster ovary cells; DEAE, diethylaminoethyl; 
dithiothreitol; EDTA, ethylene diamine tetraacetic acid; EGTA, ethyleneglycol-bis­
(0-aminoethyl ether)- N,N,N',N'- tetraacetic acid; G-protein, guanine nucleotide binding 
protein; Gi, the inhibitory G-protein; G., the 'other' G-protein; G the stimulatory 
G-protein; GDP, guanosine diphosphate; GTP, guanosine triphosphate; GTPyS, guanosine 
5'- O- (3- thio - triphosphate); GppNHp, guanylylimidodiphosphate; Hepes, 4-(2­
hydroxyethyl)-1-piperazine ethane sulfonate; MFD, Dulbecco's Modified Eagle Medium 
with F-12 Nutrient Mixture (Gibco/Bethesda Research Laboratories); NMS N­
methylscopolamine; Oxo M, oxotremorine M; PMSF, phenylmethylsulfonylfluoride; L­
QNB, L-quinuclidinylbenzilate; SDS, sodium dodecylsulfate; SHa, superhigh affinity; 
Tris, Tris(hydroxymethyl)aminomethane; buffer A, 10 mM Hepes, 5 mM MgC12, 1 mM 
EDTA, 1 mM EGTA, pH 7.4; buffer B, ice cold phosphate buffered saline, 0.1 mM 
PMSF, 1 mM benzamidine, 1 gg/m1 soybean trypsin inhibitor, pH 7.0; buffer C, 25 mM 
imidazole, 250 mM sucrose, 50 mM EDTA, 1 gg/m1 pepstatin A, 17 gg/m1 PMSF, 1 
14/m1 benzamidine, 10 gg/m1 bacitracine, 5 lig/mlleupeptin, 2 gg/mlaprotinin, 10 gg/m1 
soybean trypsin inhibitor, pH 7.4; buffer D, 20 mM Tris HC1, 1 mM EDTA, 0.1 mM 
PMSF, 1 mM DTT, 0.9% cholate, 73 mM sucrose, 5 mM MgC12, pH 8.0; buffer E, ice 
cold 50 mM sodium phosphate, 1 mM EDTA, pH 7.4. 
Materials 
[3H] Oxo M was purchased from DuPont-New England Nuclear at a specific 
activity of 87.5 Ci/mmol. Carbachol was from Aldrich Chemical Company and 9.­129 
hyoscyamine from Sigma. Oxo M, NMS and L-QNB were purchased from Research 
Biochemicals Inc. Guanine nucleotides were purchased from Boehringer Mannheim. 
Membrane preparation 
Three kinds of membrane preparations derived from Chinese hamster ovary cells 
expressing the porcifie m2 muscarinic receptor were used in the following studies. 
Except for one set of experiments using the CHOLEI,m2 cell line described in Chapter II, 
the CHO cells used were expressing the muscarinic receptor at levels of 10 to 300 pmol 
binding sites per mg protein. They were grown to near confluency in 100 mm tissue 
culture dishes and MFD culture media supplemented with 10% calf serum. For 
harvesting the media was replaced by buffer B, and the cells were manually scraped off 
the dishes. They were then pelleted for 5 minutes in a table top centrifuge and 
resuspended in twice the packed cell volume of buffer C. The resuspended cells were 
homogenized on ice with ten strokes in a Potter-Elvehjem homogenizer with teflon pestle. 
The homogenate was either used directly or to prepare membranes as described by 
Peterson & Schimerlik (1984). No difference was detected in binding studies using either 
homogenized cells or membrane preparations. The homogenates, stable at 4°C for 
several days, were kept on ice, whereas membrane preparations were frozen at -80°C. 
The Oxo M binding properties of membrane preparations seemed to be unaltered by 
freezing and thawing and were stable for several months at -80°C. For some experiments 
membrane preparations were reconstituted with purified G-proteins in an attempt to 
increase the G-protein to receptor ratio and thus the concentration of superhigh affinity 
oxotremorine M binding sites. 0.5 ml of the membrane preparation (-1 il.M receptor 
sites) were incubated with 0.1 mM acetylcholine on ice for 30 minutes, after which 1 ml 
of purified G-proteins in buffer D were added. The final cholate concentration in the 
mixture was 0.6%. The suspension was dialyzed overnight at 4°C against 0.5 L of buffer 130 
A, causing the fairly hydrophobic G-proteins to insert into the membranes. The dialysate 
was diluted 8-fold into buffer A and centrifuged at 40000 rpm for 1 hour. The resulting 
pellet was resuspended in 7 ml of buffer A, recentrifuged, resuspended in 0.5 mL of 
buffer A and frozen at -80°C. Freezing and thawing of this preparation affected the 
concentration of superhigh oxotremorine M binding sites without changing the ligands 
dissociation constant or kinetic behavior. As will be shown in this chapter results 
obtained with reconstituted preparations differ from the ones obtained with 
nonreconstituted membranes. 
G-protein purification 
G-proteins were purified from porcine atria by a method developed by Tota et al. 
(1987). Briefly, porcine atrial membranes were extracted with a digitonin/cholate 
mixture. Solubilized G-proteins were then purified employing chromatography on wheat 
germ agglutinin, DEAE Sephacel, gel filtration and octyl-sepharose columns and a 
sucrose gradient centrifugation. SDS polyacrylamide gel electrophoresis of the purified 
protein showed only three bands corresponding to the a, f3 and y subunits of the 
heterotrimeric G-protein. The preparation contained a mixture of Gil and Gi3 with no 
detectable Gs or Go. It was stored at -80°C in buffer D. 
Receptor binding assays 
To measure binding of radiolabeled ligands to the receptor membrane preparations 
were incubated with the radioligand until equilibrium was reached, i.e. 1 hour at 25°C. At 
this point unbound ligand can be separated from receptor and bound ligand by a number 
of methods. In the experiments discussed below filtration through Whatman GF/B or 
Schleicher & Schuell #32 glassfiber filters was used. Filtration was performed either on a 131 
filter manifold from Hoefer Scientific Instruments or on a Brandell cell harvester. The 
filters were washed with 4x3 ml of buffer E. Nonspecific binding was determined by 
repeating the binding experiment in the presence of a 1000 to 10000-fold excess of the 
antagonist 2-hyoscyamine. Nonspecific binding to the glassfiber filters can be quite high 
for positively charged ligands such as [3H] Oxo M and [3H] NMS. Where higher 
concentrations of these ligands (?.1 nM) were used, the filters were pretreated with 0.1% 
(v/v) polyethylene imine to reduce the background. Using filtration to separate bound 
from free ligand has the disadvantage that binding of fast-dissociating ligands may be 
underdetermined if some of the ligand dissociates during the wash steps. Therefore, a 
centrifugation method that circumvents this problem was also used, and the results from 
both procedures were compared. To use the centrifugation method, membranes were 
diluted 15-fold into buffer A to a total volume of 230 p.1.. and incubated with the 
radioligand for 1 hour at 25°C. 100 pt1 were removed and the total radioligand 
concentration was determined by scintillation counting. The remaining 130111 were 
centrifuged for 30 minutes in a Beckman airfuge at 25°C in Beckman polyallomer 
centrifuge tubes. To determine the concentration of unbound radioligand 100 µl of the 
supernatant were removed and counted. The disadvantage of this method is that the 
concentration of bound ligand has to be calculated by subtracting two large numbers with 
correspondingly large errors. Because of this error source, the following binding data 
were obtained using the filtration procedure after results from both procedures had been 
compared to assure that all of the binding was detected in the filtration assay. 
After filtration 3.5 ml of a triton-toluene based scintillation cocktail were added to 
the filter discs and equilibrated for at least one hour at room temperature. The 
radioligand was quantitated by scintillation counting in a Beckman LS6800. 132 
Equilibrium binding experiments 
Receptor concentrations were generally around 100 pM. 10 nM [3H] L-QNB was 
used to determine the total concentration of receptor binding sites, and 10 nM 
oxotremorine M was used to estimate the concentration of superhigh affinity agonist sites. 
Dissociation constants were obtained either from Scatchard analysis of direct binding data 
(Scatchard, 1949) or from competition binding curves. The latter are discussed in detail 
in Chapter II. All equilibrium binding experiments were performed at 25°C in buffer A. 
Direct binding experiments were incubated for 1 hour, competition binding curves for 2 
1/2 hours. Nonspecific binding was assessed in the presence of 100 gIVI 9-hyoscyamine. 
Kinetic studies 
In association experiments membranes were diluted to approximately 100 pM SHa 
Oxo M sites into buffer A. At time zero the labeled ligand was added, and after specified 
time periods aliquots (1 mL unless noted otherwise) were filtered through Whatman 
GF/B or Schleicher & Schuell #32 glassfiber filters on a filter manifold. Filters were 
pretreated with 0.1% polyethylene imine. Nonspecific binding was determined in a 
separate experiment using 100 JAM 2.-hyoscyamine. The concentration of bound ligand at 
equilibrium was determined at least in duplicate. (Ceq - CO, where Ceq and Ct are the 
concentrations of specifically bound ligand at equilibrium and time t, was fit to either a 
single- or a bi-exponential decay, given by A = Aoexp (-t,T) (equ. 1) and A = Afast exp 
(-t,tfast) + Amoy, exp (4,T,10,) (equ. 2), using a nonlinear least squares fitting routine 
(Duggleby, 1984). In dissociation experiments membranes were diluted to about 100 pM 
SHa Oxo M sites into buffer A and equilibrated with the labeled ligand for one hour at 
25°C. The concentration of specifically bound ligand was determined, and at time zero 
dissociation was initiated either by diluting the sample 10-fold or by adding an excess of 133 
an unlabeled ligand. Again, samples were removed at specified times and filtered. Plots 
of (Ct  Ceti) versus time were fit to a single- or bi-exponential decay given by A = A. + 
Al exp (4,T) (equ. 3) and A = A. + Afam exp (4,Tra.st) + Ask)," exp (4,Tsiow) (equ. 4). 
Unless otherwise noted all kinetic experiments were performed at 25°C. 134 
RESULTS 
Figure 4.1 shows a binding curve for [3H] Oxo M binding to a preparation of CHO 
cell membranes reconstituted with purified guanine nucleotide binding proteins as 
described under 'Materials and Methods'. The resulting G-protein to receptor ratio was 
20:1. [3H] oxotremorine binding to this preparation was saturable with a dissociation 
constant of (1.2 ± 0.1) nM. The inset shows a Scatchard plot of the same data. The linear 
Scatchard plot indicated that the receptor population observed was homogeneous and that 
binding to this population was not cooperative. The total number of [3H] Oxo M binding 
sites as obtained from least squares fitting analysis corresponded to (49 ± 2)% L-QNB 
binding sites. This was in good agreement with the competition binding experiment 
shown in Figure 4.2, which showed (53 ± 3)% of L-QNB sites having superhigh affinity 
for Oxo M with a dissociation constant of (0.57 ± 0.42) nM. 
Figure 4.3 shows the time course for association of 0.1 nM [3H] Oxo M with the 
same reconstituted membrane preparation. As can be seen from the logarithmic 
transformation in the inset association followed a single exponential and reached 
equilibrium in 15 minutes. Nonlinear least squares fitting of the (Cequ-C,) data to a single 
exponential decay yielded a reciprocal relaxation time of (0.19 ± 0.02) min-1. At 
equilibrium only 13% of the radioligand was bound which justified treating the 
association as a pseudo-first order reaction. If the mechanism by which binding occurs is 
unknown, the reciprocal relaxation time should be determined as a function of ligand 
concentration in order to determine the true, chemical rate constant(s). Also, determining 
the dependence of the association rate can provide information about the binding 
mechanism of the ligand. This dependence is shown in Figure 4.4, where the reciprocal 
relaxation time is plotted versus the Oxo M concentration. Each point in this diagram 
represents a separate experiment. Errors were between 5% and 10%, and error bars were 
omitted for the sake of clarity. The graph showed a negligible dependence of the 135 
apparent association rate on [3H] Oxo M concentration, and linear regression yielded a 
slope of (0.013 ± 0.007) min-1nM-1 and an intercept of (0.20 ± 0.03) min-1. Implications 
of this finding will be discussed in the following section. Finally, the rate of [3E1] Oxo M 
dissociation from the superhigh affinity class of sites was measured as shown in Figure 
4.5. In this experiment dissociation was initiated by the addition of 11.1M unlabeled 
Oxo M after equilibration of the reconstituted membrane preparation with 1 nM [3H] 
Oxo Ma concentration equal to the dissociation constant for the ligand. Dissociation 
followed a single exponential decay with a reciprocal relaxation time of (0.26 ± 0.01) 
min-1. Levels of bound [3f1] Oxo M remaining after about 30 minutes can be accounted 
for by nonspecific binding. The data shown are representative of four experiments with 
reciprocal relaxation times ranging from 0.22 min-1 to 0.28 min-1. 
Because of the possibility that the introduction of G-proteins foreign to the CHO 
cell membranes affects the nature of receptor G-protein interactions and thus the 
superhigh affinity class of agonist binding sites, the experiments described above were 
repeated with membrane preparations that had not undergone reconstitution. 
Homogenized CHO cell preparations or membranes were used in the following 
experiments without observing any differences. Scatchard plots of the direct binding of 
[3H] Oxo M to nonreconstituted preparations appeared linear over a range of [3H] Oxo M 
concentrations from 500 pM to 5 nM and were generally in agreement with data obtained 
from competition curves. Dissociation constants varied some from one preparation to 
another. The average value of 10 determinations was (3.12 ± 1.58) nM with an average 
of (3.62 ± 3.00) nM for Scatchard analysis and (3.00 ± 1.35) nM for competition 
experiments. The association of 1 nM [3H] Oxo M with a nonreconstituted membrane 
preparation is shown in Figure 4.6. Shortly after addition of the labeled ligand binding 
was quite rapid and reached equilibrium after about 20 minutes. This time course could 
not be adequately fit to a single exponential, but was fit well by a sum of two 
exponentials and yielded apparent association rates of (3.10 ± 0.70) min-1 and (0.22 ± 136 
0.01) min-1 for the fast and slow phase respectively.  All the binding expected from 
equilibrium measurements could be accounted for in the two phases with 40% appearing 
in the fast phase. The inset of Figure 4.6 shows a more careful determination of the fast 
association rate. With an association rate of (3.7 ± 1.5) min-1 and 47% fast phase it 
agreed well with the previous determination. As with the reconstituted preparations the 
reciprocal relaxation time was measured as a function of [3H] Oxo M concentration as 
plotted in Figure 4.7 for both the fast and slow phase.  Each data point represents a 
separate experiment. Since two exponentials were fit errors are somewhat larger than 
with the reconstituted preparation but are below 20%.  Both association rates showed 
essentially no dependence on ligand concentration. As shown in Chapter II preincubating 
membranes with guanine nucleotides such as the nonhydrolyzable GTP analogue GTPTS 
reduces the superhigh affinity binding of [311] Oxo M at equilibrium. The widely 
accepted notion is that GTPTS shifts superhigh affinity sites to lower affinity by 
uncoupling G-proteins from the receptor. Antagonist binding was not affected. 
Preincubating with guanine nucleotides can be used to examine effects of the 
concentration of unbound G-proteins. Preincubating membranes with 100 nM GTPIS for 
35 minutes at 25°C reduced equilibrium superhigh Oxo M binding by 65%, but failed to 
affect the rates or the relative amplitudes of [3H] Oxo M association. Since association 
experiments yielded different results for reconstituted versus untreated membrane 
preparations, dissociation should also be measured in both systems.  Dissociation from 
untreated membranes is illustrated in Figure 4.8. The receptor concentration in the assay 
was 14 nM. The membranes were incubated with 1 nM [3H] Oxo M for 1 hour at 25°C 
after which dissociation was initiated by addition of 1 gM unlabeled Oxo M. The 
experiment shown is representative of 10 experiments. A single exponential was clearly 
inadequate in fitting the data. Assuming a sum of two exponentials significantly 
improved the fit yielding reciprocal relaxation times of (2.7 ± 0.4) min-' for the fast phase 
and (0.11 ± 0.01) min-' for the slow phase with the amplitude of the fast phase being (53 137 
± 3)% of the total dissociating ligand. Again, dissociation was only measured from the 
superhigh affinity class of binding sites, since 1 nM [3E1] Oxo M was used in the 
preincubation. At this ligand concentration binding to the two lower affinity sites was 
insignificant. Figure 4.9 shows a different kind of dissociation experiment where 
dissociation was initiated by diluting the labeled ligand to a concentration below its 
dissociation constant. In the experiment shown the ligand was diluted 10-fold to a final 
total concentration of0.1 nM after it had been equilibrated with the membranes and the 
concentration of bound ligand had been determined. Dissociation was adequately fit by a 
single exponential decay with a reciprocal relaxation time of (0.24 ± 0.08) min* 
Equilibrium was reached after about 15 minutes, although only (39 ± 8)% of the ligand 
dissociated. This behavior was reproducible, and relaxation times measured in four 
separate experiments ranged from 0.06 min-1 to 0.24 min-1. Because of the differences 
between different kinds of membrane preparations as well as between different 
experimental protocols, dissociation from the superhigh affinity site was examined in 
detail. Only one exponential was observed in reconstituted preparations and when 
dissociation was initiated by dilution.  Competition experiments using nonreconstituted 
preparations showed an additional fast phase, and it was of interest to find factors 
controlling the amplitude of this phase. Effects on the relaxation times can also provide 
information about the processes governing the two phases. Tables 4.1-4.4 show a 
summary of the conditions tested and the resulting reciprocal relaxation times and 
amplitudes. As mentioned above, addition of guanine nucleotides reduces superhigh 
affinity Oxo M binding and thus is a third path by which dissociation of [3H] Oxo M can 
be initiated. This path should include binding of the nucleotide either to the free G-
protein or to the receptor G-protein complex and uncoupling of the complex. 
Dissociation should either take place from the receptor G-protein complex after 
nucleotide has bound or from the free receptor after uncoupling of the complex. 
Interestingly, dissociation initiated by this method was very fast and seemed to be 138 
complete in 10 seconds making it impossible to measure its relaxation time without 
special equipment. Relatively high concentrations of guanine nucleotides (equal to or 
greater than 100 nM for GTP.S) were needed to initiate dissociation, and at 101.IM GTPyS 
only half of the ligand dissociated. If on the other hand guanine nucleotides were added 
together with the radiolabeled Oxo M and allowed to equilibrate, adding an excess of 
unlabeled Oxo M yielded the same two relaxation times seen without guanine 
nucleotides. This suggested that uncoupling of G-proteins from the muscarinic receptor 
was either not involved or not rate-limiting unless PH] Oxo M dissociation was initiated 
by addition of guanine nucleotides. Supporting this conclusion were experiments 
directed at elucidating the mechanism by which reconstitution changed the kinetic 
behavior of the preparation. In the first of these experiments membranes were subjected 
to a reconstitution procedure without G-proteins, i.e. the membranes were incubated with 
acetylcholine and the G-protein storage buffer containing 0.9% cholate and then dialyzed. 
The result is shown in Figure 4.10. This preparation showed the same dissociation time 
course as preparations reconstituted with G-proteinsthat is a single exponential 
dissociation rate with a reciprocal relaxation time of (0.27 ± 0.03) min-1. In the next set 
of experiments the reconstitution procedure was examined in more detail. Three aliquots 
of membranes were either dialyzed only, incubated with acetylcholine and then dialyzed 
or treated with cholate and dialyzed. The first two samples showed the biexponential 
ligand dissociation typical for nonreconstituted membranes. In contrast the third sample 
could be adequately fit to a single exponential (T-1 = (0.23 ± 0.03) min-1). Fitting to two 
exponentials (T-1fas, = (3.7 ± 2.7) min-1 and r1siw = (0.17 ± 0.02) min-1) yielded an 
amplitude of the fast dissociation phase of (25 ± 5)% compared to (59 ± 3)% in the 
absence of detergent treatment. It was concluded that detergent treatment rather than an 
effect of the G-proteins was the factor that influenced the kinetics of Oxo M binding. 
Receptor dimers have been suggested in the literature (e.g. Potter et al., 1990), and 
it is conceivable that detergents like cholate assert their effects through disrupting 139 
receptor aggregates. Alternatively, detergents might affect the receptor directly or 
through changes in the membrane environment. Aggregates are most likely to form, 
when the receptor density is high as is the case in cells overexpressing the muscarinic 
receptor. Thus it was of interest to compare cell lines with different receptor numbers. In 
this study cell line CHOLEp,2 was used which contained the same gene for the m2 
receptor as the overexpression system discussed above, but does not overexpress the 
protein. The receptor numbers per cell (104) were two orders of magnitude lower than in 
the overexpressing cell line (106). As illustrated in Figure 4.11 Oxo M dissociation from 
this preparation was described by a single exponential decay similar to results obtained 
with reconstituted membranes. The experiment was performed under the same conditions 
as with the other preparations using 11.1M unlabeled Oxo M to initiate dissociation. The 
reciprocal relaxation time was three- to four-fold larger at (0.87 ± 0.07) mind but was 
reproducible. 
If formation and dissociation of aggregates or conformational changes within 
aggregates takes place, varying the incubation time with the labeled ligand may yield 
information about the time course of these events. Instead of an incubation time of one 
hour, which was used in previous experiments and allowed the labeled ligand to 
equilibrate, incubation periods of 1, 5 and 7 minutes were tested as shown in Table 4.1. 
After these time periods [PH] Oxo M binding reached 39, 82 and 95% of completion. 
Neither the reciprocal relaxation times nor the relative amplitudes of the two phases were 
affected suggesting that slow isomerization or aggregation steps following ligand binding 
were not rate-limiting for dissociation. Since the fast phase was only seen when a 
competing ligand was added, experiments were undertaken to test the dependence of this 
phenomenon on the nature and the concentration of the competing ligand. In addition to 
an excess of unlabeled Oxo M, the agonist carbachol and the muscarinic antagonists 2, 
hyoscyamine and L-quinuclidinylbenzylate (L-QNB) caused the same effect as shown in 
Table 4.2. It was thus not an Oxo M-specific effect and also not limited to muscarinic 140 
agonists. The amplitude of the fast dissociation phase should in some manner depend on 
the concentration of the competing ligand, since it was zero if no second ligand was 
added and, depending on the preparation, increased to 40-70% at 111M Oxo M. As 
shown in Table 1.2 increasing the concentration of unlabeled drug 100-fold failed to 
further increase the fraction dissociating with the fast relaxation time. Decreasing this 
concentration to 10 nM Oxo M also was without effect. At even lower concentrations 
only a fraction of the labeled ligand would be displaced making the signal to noise ratio 
very unfavorable. For this reason the membrane equilibrated with the radioligand were 
diluted into a larger volume of buffer A containing the unlabeled ligand. In these 
experiments the measured dissociation was caused by dilution and competition, but since 
dilution gave rise to only one slow dissociation phase, the effect of the second ligand 
could be determined. The data is summarized in Table 4.3. Three observations could be 
made: the reciprocal relaxation times were independent of the concentration of 
competing ligand, the transition between monophasic and biphasic dissociation curves 
took place between 0.5 nM and 1 nM Oxo M (or between 1 nM and 2 nM in a second set 
of experiments not shown), and the transition was rather steep. These results suggested 
that the sites that the unlabeled Oxo M interacts with were indeed superhigh affinity sites 
and that the interaction is cooperative. 
If the competing ligand has to bind to free sites on the receptor in order to cause the 
fast dissociation of the first ligand, saturating all of the superhigh affinity sites should 
prevent this effect. Indeed, if along with the [3H] Oxo M enough L-QNB was added to 
saturate the remaining sites, only a single exponential off-rate was observed as illustrated 
in Figure 4.12. The same effect was achieved, if high concentrations of [31-1] Oxo M were 
used in the preincubation. At 10 nM [3H] Oxo M only the slow dissociation phase was 
seen. This dependence is illustrated in Figure 4.13, where the relative amplitude of the 
fast dissociation phase is plotted versus the percentage of unoccupied sites after 
preincubation, and the data are summarized in Table 4.4. 141 
A dissociation experiment with porcine heart membranes suggested that they 
behave like the nonreconstituted membranes of overexpressing CHO cells. Porcine heart 
membranes were diluted to a SHa Oxo M site concentration of 120 pM and incubated 
with 1 nM [3H] Oxo M for 1 hr at 25°C. Addition of 1 p.M unlabeled Oxo M yielded two 
dissociation phases with rifts, = (1.4 ± 0.4) min-', rislow = (0.05 ± 0.02) min-1 and 
Aft A  0.59 ± 0.08. Afast  4-1slow 
Finally, the temperature dependence of ligand dissociation was looked at briefly. 
Membranes were incubated with 1 nM [3H] Oxo M at 4°C for 3.5 hours after which 
dissociation was initiated by addition of 1 ;.I.M unlabeled Oxo M. The temperature was 
kept at 4°C throughout the experiment. The resulting dissociation curve was biphasic, 
and both reciprocal relaxation times were decreased by a factor of 2-3 to (1.68 ± 0.35) 
min-1 and (0.043 ± 0.016) min-1 respectively. This relatively small temperature 
dependence was in agreement with the notion that agonist binding is mostly controlled by 
enthalpic terms (Waelbroeck et al., 1985). 142 
DISCUSSION
 
The results presented here clearly show that the mechanism of Oxo M binding to the 
superhigh affinity binding site is complex and is not a single step process as Harden et al. 
(1983) claim. Two parallel single step mechanisms, as proposed by Gil lard et al. (1987), 
are also insufficient in explaining the data. However, it is easily seen how one would 
arrive at their conclusions, if the apparent association rate is not measured over a range of 
ligand concentration. 
k1 
For a reversible single step binding mechanism of the form  RL dissociation 
k2 
is described by RL = (RL,)e-k2t and association takes the form RL = RLeq (1 
e-(kal-Fk2)t). Thus, a plot of the reciprocal relaxation time versus the ligand 
concentration should yield a straight line with a slope equal to the association rate 
constant k1 and the intercept equal to the dissociation rate constant k2. In this mechanism, 
the equilibrium dissociation constant is described by the ratio of dissociation to 
association rate constant (k2/k1). In membrane preparations reconstituted with purified G-
proteins Oxo M, association and dissociation followed a single exponential. However, 
the reciprocal relaxation time showed no or very little dependence on the Oxo M 
concentration. In a plot of reciprocal relaxation time versus ligand concentration, the 
intercept equaled the observed dissociation rate, k2, but the slope was very small and 
together with the intercept would predict a dissociation constant of 31 nM. This clearly 
disagreed with equilibrium binding data showing a dissociation constant around 1 nM. 
Thus, a more complex reaction mechanism had to be evoked. Two-step mechanisms of 
the form R+I.7.-h RL# RL' or R.-1121+LIRL generally possess two relaxation times unless 
special assumptions are made. A common assumption that reduces the number of 
relaxation times to one is that the ligand binding step is in rapid equilibrium. This kind of 
a mechanism predicts a hyperbolic ligand dependence of the apparent association rate 
contradictory to what was observed here. Alternatively, one can choose rate constants 143 
such that a formally biphasic reaction appears monophasic, because the amplitude of one 
of the phases becomes negligible. The following derivation proves, that it is possible to 
choose rate constants, for which a simple two step binding mechanism shows a single 
ligand-independent association rate equal to the dissociation rate. 
ki  k2D-4 R  RL
 
Ll  k2
 
d[r] 
=  - ki[r] dt 
d[R] 
k1[r] + k2[RL]  Oc_ + k2[L])[R] dt 
d[RL] 
k2[L][R]  k -2[RL] dt 
Assume:  RTot = [r] + [R] + [RL] 
[L] » [RTot] (pseudo-first order assumption) 
k-i, k2 >> k1, k-2 and X1 >> X2 
where Xi and X2 are the reciprocal relaxation times of the fast and slow phase. The set of 
differential equations above are solved using a Laplace-Carson transformation (Roberts, 
1977) giving: 
(k1 +1(1 + k2[L])RL0 + k2[L]Ro + kik2[1-]Rr0t [RL] 
X1X2 
(k1 + k-1 + k2[L]  X2)RL0 + k2[L]R0 + kik2[L]Rr0t 
e-Xit 
XI(X1  X2) 
(1(1 + k-1 + k2[L]  X2)RL0 + k2[L]Ro + kik:JUR-rot 
e-X2t. 
X2(X2  Xi) 
where the subscript "0" indicates concentrations at time zero. 144 
= Ic-i + k2[L] 
IC-11C-2 + k1k2[L]
 
k2[L]
 
Association: 
For ligand association Ro = RL. = 0 can be assumed, and the above equation 
simplifies to 
Icik2[L]IZ-rot [RL]  (1 - e-X2t)
 
XiX2
 
Dissociation: 
For ligand dissociation the assumption [L] = 0 is made, and the same equation 
[RLo]  -X2t yields [RL]  e 
Xi 
The reciprocal relaxation time for ligand association and dissociation equals X2. 
At [L] = 0 X2 = IC-2
 
at high ligand concentration X2 = k1
 
Thus if k1 = k2, the association rate is ligand-independent and equals the dissociation 
rate. 
In addition to predicting the right kinetic behavior this mechanism also predicts a 
linear Scatchard plot and thus agrees with all of the findings for the reconstituted system. 
G-proteins are needed for superhigh affinity agonist binding, and there are two 
alternatives to include G-proteins in the above mechanism: both r and R equal receptor 145 
G-protein complexes, and the first receptor isomerization step involves coupling of the 
receptor to a G-protein The second possibility predicts a dependence of the equilibrium 
dissociation constant on the concentration of G-proteins. However, changing the G-
protein concentration by reconstituting with different amounts of the protein may not 
result in a significant change in the effective concentration in each lipid vesicle, and thus 
this dependence may be obscured. 
Finding a bindiiig mechanism that is consistent with all the observations made in the 
nonreconstituted system, is a lot more challenging. If only the association experiments 
and the dissociation involving a competing ligand are considered, two receptor 
populations each binding ligands according to the above two-step mechanism could 
explain the data. However, neither the dilution experiments nor the dependence of the 
fast phase on unoccupied receptor sites is consistent with this notion. The dependence of 
the amplitude of the fast phase on the fractional saturation of the receptor demands an 
interaction of occupied and free superhigh affinity sites. Such an interaction necessitates 
the formationat least transientlyof a receptor dimer or higher aggregate. Aggregate 
formation or dissociation necessarily involve steps that are not first-order or pseudo-first­
order reactions, making it necessary to simulate such mechanisms since they cannot be 
solved analytically. A simulation program called "Scopfit" (Simulation Resources Inc., 
Berrien Springs, MI) was used to analyze a large number of binding mechanisms. 
Mechanisms involving up to 18 rate constants were investigated, before a model was 
found that could account for all the experimental observations. While the author is 
confident that no simpler models will fit all of the data, there may be other binding 
mechanisms of the same or greater complexity that work equally well. For this reason the 
schematic of the binding mechanism illustrated below is followed by a discussion aimed 
at pointing out the features of this model, that would have to be included in any 
alternative mechanism. 146 
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In this schematic, r and R denote different receptor conformations, and the dimer is 
asymmetric in that the two ligand binding sites have different affinity for the ligand. 
Binding initially takes place to two separate receptor populations, the monomer r and the 
dimer rr. This allows the amplitudes of the two association phases to be independent of 
the ligand concentration. Binding to each population requires an isomerization step 
before the actual ligand binding step. As pointed out during the discussion of the 
reconstituted system, this is necessary in order to make the two relaxation times ligand­
independent and equal to the observed dissociation rates. Two ligated monomers can 
interact to form the fully ligated dimer RLRL. The two binding sites on this asymmetric 
dimer have different affinity and different binding kinetics. Ligand dissociation from the 147 
fully ligated dimer can proceed by two different pathways. Each pathway involves the 
intermediate formation of a receptor dimer with one ligand molecule bound. One of these 
species, RLR, has the ligand bound in the higher affinity site, whereas the ligand is bound 
to the lower affinity site in RRL. It is assumed, that equilibrium constants for the 
individual species are such, that at ligand concentrations close to the overall dissociation 
constant the four species r, rr, RL and RLR predominate. At higher ligand concentration 
preferentially RL is formed, since it is assumed that the formation of RL from RLRL is 
favorable. All liganded species can exchange ligands in a competition experiment. In 
contrast, dilution of the ligand results in dissociation mainly from RL, since the ligand is 
bound with higher affinity in RLR. If one assumes that the ligand dissociates slowly 
from RL and rapidly from RLR, this results in mainly slow dissociation in dilution 
experiments and a slow and a fast phase in competition experiments. At high ligand 
concentrations, where RL is favored over RLR, dissociation is also slow. As discussed 
for the proposed binding mechanism for the reconstituted preparation, G-proteins are 
either included in all receptor species or are bound in the isomerization steps from r to R 
and from rr to RR. As predicted from the presence of different ligand affinities, the 
Scatchard plot for this model is somewhat nonlinear and indicates negative cooperativity. 
However, at ligand concentrations close to half saturation (within 5-fold from the 
apparent dissociation constant) the deviation from linearity is fairly small, and the 
predicted Scatchard plot is in agreement with the experimental data. 
At this level of complexity, the proposed model can not reasonably be used for data 
fitting. While some rate constants have to he equal to the measured reciprocal relaxation 
times, others can only be determined relative to each other. Also, when choosing rate 
constants, the constraint on equilibrium constants imposed by the presence of a closed 
(k9  kii )
1.
loop has to be considered  Figures 4.14 through 4.18 are
k8  k12 kio  kia 
designed to show that it is possible to choose rate constants for which the proposed model 
agrees with all of the experimental observations. The lines in these figures do not 148 
represent a fit to the data shown as squares, but are the result of simulations of the model 
under appropriate conditions. It should be pointed out that the curves obtained from the 
simulations may not formally be described by one or two exponentials, but are well fit by 
these approximations. Figures 4.14 and 4.15 show association time courses at ligand 
concentrations of 1 nM and 10 nM, respectively. Since the model agrees with measured 
association rates at both ligand concentrations, it follows that the model predicts the right 
ligand-dependence of the association rate. Figures 4.16 and 4.17 show dissociation time 
courses for reactions initiated either by competition with 1000-fold excess of a second 
ligand or by a 10-fold dilution. Figure 1.16 shows an experimental and a simulated 
Scatchard plot. 
The binding mechanism that is described for the reconstituted membranes and that 
also seems to fit systems with low receptor concentrations such as the described 
CHOipm2 cells, follows from this more complicated model, if dimer formation is not 
allowed. 
To end this discussion it may be pointed out that the proposed model or variations 
thereof may account for some seemingly obscure results obtained with other G-protein 
coupled receptors as mentioned in the introduction. Formation of higher affinity binding 
sites may look like formation of nondissociable ligand as was seen by Bharucha and 
Tager (1990) with glucagon receptors. The different relative amplitudes of the two 
phases in association and dissociation experiments observed by Sinkin et al. (1993) with 
histamine receptors might also be explained. In the association reaction, the amplitudes 
are mostly controlled by the relative amounts of r and rr, whereas the equilibrium 
constants relating RLR and RL largely determine the amplitudes in the dissociation 
reaction. On this admittedly very superficial level it seems that the suggested binding 
mechanism may be adapted to explain the ligand binding behavior of different G-protein 
coupled receptors. 149 
Figure 4.1	  Binding curves for [3H] Oxo M to a preparation of CHO cell membranes 
reconstituted with purified G-proteins. 
The final concentrations in the assay were 624 pM L-QNB sites, 300 pM 
SHa Oxo M sites and 12.5 nM [35S] GTRTS binding sites. The 
concentrations of [3H] Oxo M ranged from 20 pM to 10 nM, and the 
obtained values for bound [3H] Oxo M were corrected for nonspecific 
binding. Nonspecific binding was determined in the presence of 100 gM St­
hyoscyamine. All samples were incubated at 25°C for 30 minutes. The 
inset shows a Scatchard plot of the binding data, which was fit by linear 
regression to give a dissociation constant of (1.2 ± 0.1) nM. E
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Figure 4.2	  Oxo M displacement of specifically bound [3H] L-QNB. 
A preparation of CHO cell membranes reconstituted with G-proteins was 
diluted into buffer A to a L-QNB site concentration of 125 pM. The dilution 
was preincubated at 25°C for 20 minutes with different concentrations of 
Oxo M ranging from 10 pM to 1 mM. 1.6 nM [3H] QNB were added and 
equilibrated for 90 minutes at 25°C. Samples were then filtered through 
Whatman GF/B glass fiber filters soaked in 0.1% polyethylene imine, 
equilibrated with nonaqueous scintillation coctail and quantitated by liquid 
scintillation counting. Nonspecific binding of [3H] L-QNB was determined 
in the presence of 100 gM 2.-hyoscyamine. Fitting of the data to a model 
assuming three independent classes of sites yielded F1 = 0.53 ± 0.03, F2 = 
0.44 ± 0.05, K1 = (0.57 ± 0.42) nM, K2 = (0.66 ± 0.42) gM and K3 = (10 ± 
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Figure 4.3	  Association of 0.1 nM [3H] Oxo M with a reconstituted membrane 
preparation. 
CHO cell membranes reconstituted with purified G-proteins were diluted 
into buffer A to give a L-QNB site concentration of 412 pM and a guanine 
nucleotide binding site concentration of 11.6 nm. At time 0 0.1 nM [3H] 
oxotremorine M was added, and at specified times 1 ml aliquots were 
filtered through Whatman GF/B glass fiber filters soaked in 0.1% 
polyethylene imine. Bound radioligand was quantitated by liquid 
scintillation counting. The experiment was performed at 25°C. The inset 
shows a semilogarithmic plot (Cequ - CO versus time. (Cev, - CO was fit to 
equ. 1 yielding r1 = (0.19 ± 0.02) min-1 at a total SHa Oxo M binding site 
concentration of (18 ± 1) pM. 0  2  4  6  8  10 
Time (min) 
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Figure 4.4  Ligand dependence of the reciprocal relaxation time of [3F11 Oxo M in 
reconstituted membranes. 
Each data point represents a separate experiment, and experiments were 
performed as described under 'Materials and Methods'. Total L-QNB site 
concentrations were approximately 400 pM, SHa Oxo M sites were 20 pM 
and the temperature was 25°C. Linear regression yielded a slope of (0.013 ± 
0.007) min-1 nM-1 and an intercept of (0.20 ± 0.03) min-1. ,  I  I  I 
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Figure 4.5  Dissociation of [3H] Oxo M from the highest affinity site in a reconstituted 
membrane preparation. 
CHO cell membranes reconstituted with G-proteins were diluted into buffer 
A to give a L-QNB site concentration of 2.7 nM, a SHa Oxo M site 
concentration of 0.18 nM and a guanine nucleotide binding site 
concentration of 77 nM. The membranes were incubated with 1 nM [3H] 
Oxo M for 1 hour at 25°C. Two 1 ml samples were removed and filtered 
through glass fiber filters. At time zero 1 I.LM Oxo M (unlabeled) was added, 
and at specified times 1 ml samples were removed and filtered. Bound 
ligand was quantitated by liquid scintillation counting. The inset shows a 
semilogarithmic plot of the data. Non linear least squares fitting of the data 
to equ. 3 yielded t-1 = (0.26 ± 0.01) min-1. 8000 
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Figure 4.6	  Association of 1 nM [3H] Oxo M with nonreconstituted membranes. 
A nonreconstituted membrane preparation was diluted into buffer A to give 
a L-QNB site concentration of 1.4 nM, 200 pM SHa Oxo M sites and a 
guanine nucleotide binding site concentration of 15 nM. The experiment 
was performed at 25°C as described for the reconstituted preparation except 
that 1 nM of the radioligand was used. Fitting (Cequ - C) to equ. 2 yielded 
Afa5t 
A fas t =  (3.10 ± 0.70) min-I, risiow = (0.22 ± 0.01) min-1 and A tlfast + risiow 
0.40 ± 0.04. The inset shows an experiment using similar conditions but 
shorter incubation periods and yielded rlfau = (3.7 ± 1.5) min-1 at a SHa 
Oxo M site concentration of 7 pM. 20000d 
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Figure 4.7	  Ligand dependence of the fast and slow reciprocal relaxation times of [3H] 
Oxo M in nonreconstituted membranes. 
Each data point represents a separate experiment performed at 25°C with 
final SHa Oxo M site concentrations of 200 pM.  The data was fit by linear 
regression to give a slope of (0.072 ± 0.066) min-1 nM-1 and an intercept of 
(2.81 ± 0.38) for the fast phase and a slope of (-0.001 ± 0.008) min-1 nM-1 
and an intercept of (0.29 ± 0.046) for the slow phase. 162 
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Figure 4.8  Dissociation of [3H] Oxo M from nonreconstituted membranes initiated by 
addition of unlabeled Oxo M. 
Nonreconstituted membranes were diluted into buffer A to a L-QNB site 
concentration of 14 nM, a SHa Oxo M site concentration of 0.5 nM and a 
guanine nucleotide binding site concentration of 154 nM.  The sample was 
incubated with 1 nM [3H] Oxo M for 1 hour at 25°C. Two 0.5 ml samples 
were filtered. At time zero 1 g/v1 unlabeled Oxo M was added, and at 
specified times 0.5 ml aliquots were removed and filtered. Bound 
radioligand was quantitated by liquid scintillation counting and fit to equ. 4 
using nonlinear least squares fitting yielding -cif-as,  (2.7 ± 0.4) min- r islow 
Afast = (0.11 ± 0.01) min-' and  A  0.53 ± 0.03. 
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Figure 4.9	  Dissociation of [3H] Oxo M from nonreconstituted membranes initiated by 
dilution. 
Nonreconstituted membranes were diluted into buffer A to give 85 nM 
L-QNB sites, 0.3 nM SHa Oxo M sites and 13 nM GTP7S sites. After a 1 
hour incubation with 1 nM [3H] Oxo M at 25°C, two 100 gl samples were 
removed and filtered. At time 0 the mixture was diluted 10-fold into buffer 
A, and at specified times 1 ml aliquots were removed and filtered. Data 
were fit to equ. 3. T-1 was (0.24 ± 0.08) min- and (39 ± 8)% of the ligand 
dissociated. 3000  I  I  I 
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Figure 4.10 PH1 Oxo M dissociation from membranes "reconstituted" without G-
proteins. 
0.5 ml of membranes were incubated with 0.1 mM acetylcholine on ice for 
30 minutes after which 1 ml of buffer D (G-protein storage buffer) was 
added. The mixture was dialyzed and centrifuged as described under 
"Materials and Methods". The membranes were resuspended in the original 
volume, diluted 100-fold to give 160 pM SHa Oxo M sites and 580 pM L­
QNB sites and equilibrated with 1 nM [3H] Oxo M. Dissociation was 
initiated by addition of 1 p.M unlabeled Oxo M and 0.5 ml aliquots were 
filtered. Nonlinear least squares fitting to equ. 3 yielded r1 = (0.27 ± 0.03) 
min-i. 4000 ­
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Figure 4.11 Dissociation of [3H] Oxo M from homogenized CHOLEpira cells. 
CHOLEI,,2 cells were harvested and homogenized as described under 
"Materials and Methods". Homogenized cells were diluted 15-fold to give a 
L-QNB site concentration of 247 pM and a SHa Oxo M site concentration of 
52 pM. The sample was equilibrated with 2 nM [3H] Oxo M for 1 hour at 
25°C. At time 0 dissociation was initiated by addition of 1 AM unlabeled 
Oxo M, and at specified times 0.5 ml aliquots were removed and filtered. 
Data were fit to equ. 3 yielding T-1 = (0.87 ± 0.07) min-1. 3500 
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Figure 4.12 Dissociation of [3H] Oxo M in the presence of saturating concentrations of 
L-QNB. 
Membranes were diluted into buffer A to a final L-QNB site concentration 
of 50 pM and a final SHa Oxo M site concentration of 6 pM.  The dilution 
was incubated with 1 nM [3H] Oxo M and 0.2 nM QNB for 90 minutes at 
25°C. At time 0 dissociation was initiated by addition of 1 tM unlabeled 
Oxo M, and at specified times 5 ml aliquots were removed and filtered. 
Fitting the data to equ. 3 yielded ri = (0.06 ± 0.01) min-1. 2000­
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Figure 4.13 Dependence of the amplitude of the fast dissociation phase on the 
percentage of unoccupied sites. 
Membranes were diluted into buffer A to a L-QNB concentration of 13 nM 
and a SHa Oxo M site concentration of 0.15 nM. Membranes were then 
incubated with concentrations of [3H] Oxo M ranging from 0.1 nM to  10 
nM, and the percentage of unoccupied sites was determined. At time zero 
1 ILM unlabeled Oxo M was added to initiate dissociation.  The dissociation 
curves were fit by nonlinear least squares fitting, and the relative amplitude 
of the fast phase was plotted versus the percentage of unoccupied sites. 100  I 
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Figure 4.14 Simulated and experimental association rate at 1 nM ligand. 
The experimental data were obtained at a SHa Oxo M site concentration of 
100 pM as described under 'Materials and Methods' and are shown as 
squares. The line is the result of simulating the proposed binding model 
under the following conditions: k1 = 0.2 min-1, k2 = 100 min-1, k3 = 100 min­
1 nM-1, k4 = 0.2 min-1, k5 = 0.005 min-1 nM-1, k6 = 1.125 min-1, k7 = 100000 
min-1, k8 = 10 min-1 nM-', k9 = 0.1 min-1, k,0 = 100 min-1 nM-', k1, = 4 min-1, 
k12 = 4000 min-1 nM-1, k,3 = 1000 min-1,1(14 = 0.1 min-1 nM-', k15 = 400 min­
1, k,6 = 4 min-1, ro = 0.06 nM, rro = 0.02 nM, Lo = 1 nM, Ro = RLo = LRRLo 
= RLR0 = LRRO = RR, = 0 where the subscript "0" denotes initial 
concentrations at time zero. The software used was "Scopfit". 100 
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Figure 4.15 Simulated and experimental association rate at 10 nM ligand. 
Experimental data shown as squares were obtained as described under 
'Materials and Methods' at a final SHa Oxo M site concentration of 0.1 nM. 
The line resulted from simulating the proposed binding model. The 
parameters used in the simulation were the same as for Figure 4.14 except 
for L. = 10 nM, ro = 0.02 nM and rr. = 0.04 nM. 100 
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Figure 4.16 Simulated and experimental dissociation rate involving competition with a 
second ligand. 
Experimental data (shown as squares) were obtained from a dissociation 
experiment involving equilibration of 0.1 nM SHa Oxo M sites with 1 nM 
[3H] Oxo M and addition of 1 RM unlabeled Oxo M. The experiment was 
simulated by first simulating the association of 1 nM ligand and using the 
obtained equilibrium concentrations as starting conditions. A second ligand 
x was introduced into the model with xo (concentration of x at time 0) being 
1 RM. Rate constants were the same as for Figure 4.14. 100 
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Figure 4.17 Simulated and experimental ligand dissociation after dilution. 
The squares represent a dissociation experiment involving equilibration of 
0.1 mM SHa Oxo M sites with 1 nM [3H] Oxo M followed by a 10-fold 
dilution. The experiment was simulated using initial concentrations 10-fold 
lower than the equilibrium concentrations obtained from simulating the 
association of 1 nM ligand. Rate constants were the same as for Figure 4.14. 1  I 
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Figure 4.18 Simulated and experimental Scatchard plot. 
Experimental data are shown as squares and were obtained as described for 
Figure 4.1 at a SHa Oxo M site concentration of 0.58 nM. The association 
of different ligand concentrations was simulated and the resulting 
equilibrium concentrations were used to produce the curve. Rate constants 
were the same as for Figure 4.14 except for k3 = 15 min-1 nM-1, k 12 = 600 
min-1 nM-1 and k10 = 13 min-1 nM-1. These changes reflect the somewhat 
higher dissociation constant seen with the experimental data, but do not 
influence the kinetic behavior predicted by the proposed model. ro was 
0.3 nM and rro 0.14 nM. I  I  I  I  1  I 
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Table 4.1  [3H] Oxo M dissociation in the presence of guanine nucleotides and after 
short incubation periods. 
The table summarizes the results of a number of dissociation experiments. 
The first column shows the conditions during ligand binding, i.e. before 
dissociation was initiated. SHa Oxo M binding site concentration was 
approximately 0.1 nM in all experiments. The second column gives the 
nature and concentration of the competing ligand that was added to initiate 
dissociation of j3H] Oxo M. The remaining three columns show the results 
of nonlinear least squares fitting of the data to equ. 4. Preincubation 
conditions 
Competing ligand  T 1(fast) (min -1) 
±SD 
T- 1(slow) (min -1) 
±SD 
A(fast) (%) 
1 nM [H3]Oxo M  1pM Oxo M  2.76±0.37  0.11±0.01  53±3 
for 1 hr 
1 nM [H3]Oxo M +  1pM Oxo M  3.60±0.87  0.18±0.03  64±6 
100pM GppNHp 
for 1 hr 
1 nM [H3]Oxo M +  1pM Oxo M  4.82±1.38  0.10±0.01  59±5 
1 OpM GDP 
for 1 hr 
1 nM [H3]Oxo M  1pM Oxo M  4.49±0.57  0.53±0.08  74±4 
for 1 min 
1 nM [H3]Oxo M  1pM Oxo M  6.03±0.98  0.48±0.04  65±3 
for 5 min 
1 nM [H3]Oxo M  1pM Oxo M  2.58±0.19  0.33±0.04  71±3 
for 7 min 
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Table 4.2  Effect of the nature and concentration of the competing ligand on [3H] Oxo 
M dissociation.
 
Approximately 0.1 nM SHa Oxo M sites were incubated with 1 nM [3H]
 
Oxo M for 1 hour at 25°C. At this point a second ligand, specified in the
 
second column of this table, was added to initiate dissociation of [3H] Oxo 
M. Columns 3-5 show the results of nonlinear least squares fitting of the 
data to equ. 4. Preincubation 
conditions 
1nM [H3]Oxo M 
for 1 hr 
1nM [H3]Oxo M 
for 1 hr 
Table 4.2 
Competing ligand 
100pM Carbachol 
101.iM Hyoscyamine 
2W QNB 
100pM Oxo M 
100nM Oxo M 
10nM Oxo M 
1nM Oxo M 
T-1(fast) (Min-1) 
±SD 
4.39±0.74 
2.65±0.59 
4.21±1.53 
3.13±0.60 
3.55±0.45 
3.25±1.17 
3.16±2.49 
T-1 (slow) (Min-1) 
±SD 
0.12±0.01 
0.09±0.01 
0.09±0.01 
0.10±0.01 
0.11±0.01 
0.18±0.03 
0.22±0.19 
A(fast) (%) 
68±4 
56±4 
59±5 
52±5 
61±3 
47±7 
67±22 189 
Table 4.3  Effect of the concentration of the competing ligand on [3H] Oxo M 
dissociation. 
Approximately 1 nM SHa Oxo M sites were incubated with 1 nM [3H] Oxo 
M for 1 hour at 25°C. At time zero dissociation of [3H] Oxo M was initiated 
by diluting the sample 10-fold into buffer A containing the concentration of 
unlabeled Oxo M specified in the first column. Data were fit to equ. 4, and 
the results are shown in columns 2-4.. [Oxo M] 
(nM) 
T-1 (fast) (mm-1) 
±SD 
T-1(slow) (min-1) 
±SD 
A(fast)/(A(fast)+A(slow))
(%) 
0.1  0.34±0.01  0 
0.5  0.47±0.01  0 
1  2.53±0.34  0.14±0.01  36±2 
2  4.10 ±0.70  0.13±0.01  43±2 
5  2.89±0.22  0.12±0.01  43±1 
10  2.21±0.12  0.11±0.01  33±1 
100  4.15±0.48  0.14±0.01  34±1 
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Table 4.4	  Effect of the fractional saturation of the receptor on the dissociation of [3H] 
Oxo M. 
Approximately 0.1 nM SHa Oxo M sites were incubated for 1 hour at 25°C 
with the concentration of [3H] Oxo M or [3H] Oxo M andL- QNB listed in 
the first column. 1µM unlabeled Oxo M was used to initiate dissociation. 
Data obtained were fit to equ. 4, and the results are shown in columns 3-5. Preincubation  Competing ligand  T-1(fast) (min-1)  T-1(slow) (min-1)  A(fast) (%) 
conditions  ±SD  ±SD 
1nM [H3]Oxo M +  1pM Oxo M  0.06±0.01  0 
0.2nM QNB 
0.1nM [H3]Oxo M  1pM Oxo M  3.62±1.02  0.15±0.01  46±5 
0.5nM [H3]Oxo M  111M Oxo M  1.14±0.31  0.13±0.02  44±7 
1nM [H3J0xo M  1pM Oxo M  2.55±0.96  0.13±0.02  39±7 
2nM [H3]Oxo M  1pM Oxo M  0.88±0.24  0.19±0.05  23±3 
5nM [H3]Oxo M  1pM Oxo M  1.16±0.33  0.17±0.01  25±4 
10nM [H3]Oxo M  1pM Oxo M  0.12±0.03  0 
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CHAPTER V
 
CONCLUSIONS
 
The studies presented here were designed to gain a better understanding of ligand 
binding to the muscarinic receptor. The receptor subtype used was the recombinant 
porcine m2 muscarinic receptor expressed in Chinese hamster ovary cells. The m2 
subtype is the only muscarinic receptor subtype expressed in atrial tissue. Therefore, 
results obtained in this study should be directly comparable to findings with porcine atrial 
membranes. Indeed, no differences between equilibrium ligand binding and 
oxotremorine M binding kinetics were observed between porcine atrial membranes and 
membranes containing the recombinant receptor. 
Although agonist binding was studied extensively, many questions remain 
unanswered. Agonist binding data presented fit reasonably well to a model assuming 
three independent classes of sites. This finding has to be reconciled with the traditional 
view of how muscarinic receptors function. One important question is which classes of 
sites are active in eliciting a physiological response. Whole cells show only two classes 
of binding sites. Since both classes are insensitive to pertussis toxin treatment, it is 
assumed that they correspond to the high and low agonist affinity classes seen in 
membranes. The agonist affinities are approximately an order of magnitude lower in 
whole cells, but increase to the values observed with membrane preparations, if the cells 
are permeabilized with 0.05% digitonin. The simplest explanation for this finding is that 
the cytoplasm contains an inhibitor of agonist binding that is diluted upon 
permeabilization. Several cations inhibit ligand binding to the muscarinic receptor. It 
will be interesting to see if any of them are present at high enough concentrations in the 
cytoplasm to cause this effect. Alternatively, the lower affinity observed in whole cells 
may be due to an aspect of membrane organization, e.g. the membrane potential or a 
specific organization of membrane proteins in arrays. 194 
In addition to the two sites seen in whole cells, membranes also show a class of 
binding sites with superhigh affinity for agonists. This class is sensitive to guanine 
nucleotides and pertussis toxin as shown in Chapter II. Together with the reconstitution 
experiments presented this is evidence for the involvement of G-proteins in superhigh 
affinity agonist binding. All results presented here are in agreement with the superhigh 
affinity class of sites being a receptor G-protein complex. The amount of superhigh 
affinity binding seems to be limited by the availability of G-proteins. It is likely that this 
site is not observed in whole cells because of the concentration of guanine nucleotides in 
the cytoplasm uncoupling the complex. Although complex formation with G-proteins is 
assumed to be a step in the pathway by which muscarinic receptors elicit a physiological 
response, EC50s from physiological assays disagree with the superhigh affinity class 
being the active species of the receptor. However, one has to keep in mind that ligand 
binding experiments in whole cells are not equilibrium measurements, but represent a 
steady state. In a steady state measurement the EC50 is the result of all the steps involved 
and may be lower than the affinity of one or some of the intermediates. 
The difference between the high and low affinity classes of sites is unclear. In 
whole cells the appearance of the low affinity state for agonists was dependent on 
receptor density, and at very low receptor per cell numbers only the high agonist affinity 
was seen. This dependence points to receptor aggregation as a possible explanation. At 
the same low receptor density that gives only one agonist affinity in whole cells, 
membranes show three agonist affinities. The reason for this difference may be 
differences in the surface area in whole cells and membrane vesicles/sheets. Studies are 
underway to test this hypothesis. If receptors are organized in patches rather than 
distributed randomly and the membrane surface area is smaller in membrane preparations 
than in whole cells, it is conceivable that aggregation is different in whole cells and 
membrane preparations. The one site seen in whole cells with low receptor density could 
be a receptor monomer or an aggregate. Monomers would seem to be favored at low 195 
receptor density. On the other hand, there may be areas of the plasma membrane where 
receptors are inserted preferentially. In these areas receptor might form arrays. Once 
these arrays are occupied, additional receptors may be distributed over other areas of the 
plasma membrane. 
Additional support for receptor aggregation comes from kinetic studies of 
oxotremorine M binding to the superhigh affinity class of sites. Although these studies 
only involve one clais of sites, receptor-receptor interactions have to be postulated to 
explain all of the results presented in Chapter IV. If receptors can interact in the presence 
of G-proteins to give rise to complex superhigh affinity agonist binding kinetics, they 
may also interact in the absence of G-proteins resulting in a different agonist affinity. 
Thus, the model proposed to explain superhigh affinity oxotremorine M binding may be 
expanded to include the two lower affinity classes of sites. This hypothesis could be 
tested by cross-linking studies. Cross-linking experiments with glutaraldehyde in the 
presence of high agonist concentrations failed to show enough receptor dimers and 
trimers to account for the observed high and low affinity fractions of sites (Dr. G. 
Peterson, unpublished results). However, in addition to monomers and some dimers and 
trimers, cross-linking resulted in the formation of high molecular weight structures unable 
to penetrate SDS polyacrylamide gels. Receptor aggregates might be hidden in these 
structures. Analogy with the model for superhigh affinity agonist binding suggests an 
alternative explanation. High agonist concentrations may promote receptor dissociation, 
and cross-linking studies at lower agonist concentrations may be more suitable to 
demonstrate receptor aggregation. 
Detergent treatment abolished receptor-receptor interactions involved in superhigh 
affinity agonist binding. Interestingly, detergent-treatment seemed to also decrease the 
high affinity fraction of binding sites in membranes and high detergent concentrations 
favor low affinity agonist binding to purified pm2 muscarinic receptors (Dr. G. Peterson, 
unpublished results). Detergents may change receptor interactions by promoting a 196 
conformational change of the receptor. This possibility is supported by results obtained 
from the pH dependence studies. Upon detergent-treatment membranes showed a shift in 
the pKA governing antagonist binding. No shift in the pKA involved in agonist binding 
was seen. The classes of sites having different agonist affinity show the same pKA. 
Thus, a conformational change affecting the fractions of high and low agonist affinity 
sites is not expected to yield a shift in pKA for agonists. 
pH dependence studies were not successful at identifying the receptor residue 
interacting with the positive charge on muscarinic ligands. It was shown that agonist and 
antagonist binding was governed by different pKAs. Neither pKA belongs to aspartates 69 
and 97. Aspartate 103 is likely to be responsible for the pKA seen with agonists. The 
antagonist pKA may be due to a conformational change involving aspartate 120. Thus, 
the role of aspartate 120 should be studied in more detail. Maybe the more conservative 
mutation D120E rather than DI2ON will result in expressed protein for ligand binding 
studies. 
In summary, the presented study yielded new information about ligand binding; the 
two major findings being the model describing agonist binding to the superhigh affinity 
site and the differences between agonist and antagonist binding suggested by the pH 
dependence studies. In addition, the study points to possible future experiments, some of 
which were pointed out in this chapter. 197 
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